Chondrodysplasia Blomstrand Type

Mendelian MONDO:0008970 Pathograph 20 Show in embeddings browser Skeletal disorder of parathyroid hormone signaling Lethal osteochondrodysplasia

Blomstrand chondrodysplasia (Blomstrand osteochondrodysplasia, BOCD, MIM #215045) is an ultra-rare, perinatally lethal autosomal recessive osteochondrodysplasia caused by biallelic loss-of-function variants in PTH1R, the gene encoding the type 1 parathyroid hormone / parathyroid hormone-related peptide (PTH/PTHrP) receptor. In the normal growth plate, PTHrP acting through PTH1R holds chondrocytes in the proliferative pool and delays their exit into hypertrophy, as the distal limb of an Indian hedgehog-PTHrP negative feedback loop. When the receptor cannot bind ligand or generate a second messenger, that brake is removed: chondrocytes differentiate prematurely, the proliferative and hypertrophic zones become hypoplastic and disorganized, and endochondral ossification runs far ahead of gestational age. Affected fetuses show extremely advanced skeletal maturation, generalized osteosclerosis and severe tetramicromelia with dumbbell-shaped, metaphyseally flared long bones, together with polyhydramnios, hydrops fetalis, thoracic hypoplasia and a characteristic face with retro-micrognathia and a protruding tongue. Because PTHrP-PTH1R signaling also drives epithelial-mesenchymal interactions outside the skeleton, affected fetuses additionally lack nipples and breasts and have severely impacted teeth. The condition is uniformly lethal in utero or shortly after birth. It is divided by skeletal severity into type I, caused by complete inactivation of PTH1R, and the milder type II, in which a near-complete inactivation leaves a low level of residual receptor activity; both are lethal. It is the mechanistic mirror image of Jansen metaphyseal chondrodysplasia, in which constitutively activating PTH1R variants delay chondrocyte differentiation.

Ask OpenScientist

Ask a research question about Chondrodysplasia Blomstrand Type. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
7
Pathophys.
15
Phenotypes
1
Gaps
20
Pathograph
1
Genes
2
Medical Actions
2
Subtypes
3
Differentials
1
Models
3
References
1
Deep Research
🏷

Classifications

ISDS Skeletal Nosology
parathyroid hormone signaling
👪

Inheritance

1
Autosomal recessive HP:0000007
Blomstrand chondrodysplasia segregates as an autosomal recessive trait. Affected fetuses carry homozygous or compound heterozygous PTH1R alleles; parental consanguinity and recurrence of the phenotype in sibs of both sexes born to unaffected parents were the original evidence for recessive inheritance, and have since been confirmed molecularly.
Autosomal recessive inheritance
Show evidence (3 references)
PMID:10552065 SUPPORT Human Clinical
"Autosomal recessive inheritance has been proposed because of parental consanguinity of affected siblings in all reported cases, including this one."
States the consanguinity/sib-recurrence basis for recessive inheritance across the reported case series.
PMID:9268097 SUPPORT Human Clinical
"This recurrence affecting a male and a female fetus, born to the same couple, suggests autosomal recessive inheritance."
Recurrence in a male and a female sib of unaffected parents demonstrates autosomal rather than X-linked recessive transmission.
PMID:27353973 SUPPORT Human Clinical
"Homozygous and compound heterozygous mutations in PTHR1 gene have been implicated in the pathogenesis of this chondrodysplasia."
Confirms that the causal PTH1R genotypes are biallelic (homozygous or compound heterozygous).
◆

Subtypes

2
BOCD type I (complete PTH1R inactivation)
The severe form, in which the PTH1R allele is completely inactivated and no receptor activity remains. The reported type I allele is a homozygous nonsense substitution, R104X, which truncates the receptor. Type I is the more severe end of the skeletal spectrum on which the two-type division of Blomstrand osteochondrodysplasia is based; the division is by severity of the skeletal abnormalities, and the molecular correlate is how much residual receptor activity survives.
Show evidence (3 references)
DOI:10.1210/jc.2006-0300 SUPPORT Human Clinical
"BOCD can be divided into two types, depending on the severity of the skeletal abnormalities."
States that the disease is divided into two types on skeletal severity, which is the basis for these subtype entries.
DOI:10.1210/jc.2006-0300 SUPPORT Human Clinical
"In one of the type I BOCD cases, a homozygous nonsense mutation (R104X) was found, resulting in a truncated PTHR1."
Supplies the allelic anchor for type I.
DOI:10.1210/jc.2006-0300 SUPPORT Human Clinical
"In combination with data presented in literature, we conclude that type I BOCD is caused by a complete inactivation of the PTHR1, whereas low levels of residual activity due to a near complete inactivation of the PTHR1 result in the relatively milder presentation of type II BOCD."
States the molecular basis assigned to type I, complete receptor inactivation.
BOCD type II (near-complete PTH1R inactivation with residual activity)
The relatively milder form, in which the receptor is not completely inactivated and a low level of residual activity survives. Two type II alleles are described: a homozygous intronic substitution that creates a novel splice site preferentially used in patient dermal fibroblasts, while the wild-type transcript persists at low levels; and the recurrent homozygous P132L missense substitution, which functional analysis shows to retain low residual activity. Type II is still perinatally lethal; the contrast with type I is in the severity of the skeletal abnormalities, not in survival.
Show evidence (4 references)
DOI:10.1210/jc.2006-0300 SUPPORT Human Clinical
"We performed mutation analysis in two families with type I and in three families with the less severe form of BOCD type II."
Establishes type II as the less severe form and the families in which it was characterised.
DOI:10.1210/jc.2006-0300 SUPPORT Human Clinical
"In the other two families with type II BOCD, a previously identified homozygous missense mutation (P132L) was found."
Assigns the recurrent P132L allele to type II.
DOI:10.1210/jc.2006-0300 SUPPORT In Vitro
"Functional analysis demonstrated that the P132L mutant had low residual activity."
The functional result that places P132L in the near-complete-inactivation group rather than the null group.
+ 1 more reference
?

Discussions and Knowledge Gaps

1
Why is generalized osteosclerosis a cardinal radiographic feature of human Blomstrand chondrodysplasia when the PTH/PTHrP receptor-null mouse is reported for accelerated chondrocyte differentiation and mid-gestation lethality rather than for increased bone density?
HUMAN MODEL MISMATCH blomstrand_osteosclerosis_absent_from_mouse_null
Attached to
pathophysiology#Premature and Advanced Endochondral Ossification phenotypes#Generalized osteosclerosis
The cellular lesion — accelerated chondrocyte differentiation — is faithfully reproduced in the Pth1r-null mouse, and the review literature states that PTH1R-ablated animals show premature endochondral ossification. But the defining human radiographic finding, generalized osteosclerosis, is not what the mouse work reports; most null embryos die in mid-gestation, before a skeleton dense enough to assess radiographically has formed. It is therefore unresolved whether human osteosclerosis is simply the accumulated end state of premature ossification carried to 25-40 weeks of gestation, or whether it additionally requires a species-specific or later-gestation contribution (for example altered osteoclast activity in the absence of PTH1R signaling in bone) that the mouse never lives long enough to display. This matters because it determines whether the mouse can be used to test any intervention aimed at the sclerotic phenotype.
Proposed experiments
Chondrocyte-restricted, late-gestation Pth1r deletion with skeletal radiography
blomstrand_conditional_pth1r_late_gestation
Delete Pth1r conditionally in growth plate chondrocytes at a stage that bypasses mid-gestation lethality, and image the skeleton radiographically and by micro-CT through late gestation and the perinatal period, to test whether generalized osteosclerosis emerges once the animal survives long enough.
Would support
phenotypes#Generalized osteosclerosis
Supporting outcome
  • Radiographic bone density rises progressively once mid-gestation lethality is bypassed, reproducing the human sclerotic phenotype from the same chondrocyte-autonomous lesion
Refuting outcome
  • Late-gestation chondrocyte-restricted deletion accelerates ossification without producing generalized osteosclerosis, implying an additional non-chondrocyte or human-specific contribution
Quantitative mineral density distribution in human Blomstrand bone
blomstrand_bse_histomorphometry
Quantitative backscattered-electron imaging and histomorphometry on non-decalcified bone from molecularly confirmed Blomstrand fetuses, compared with gestational-age-matched controls, to establish whether the radiographic osteosclerosis reflects true tissue hypermineralization or the geometry of prematurely ossified, structurally abnormal bone.
Would support
pathophysiology#Premature and Advanced Endochondral Ossification
Supporting outcome
  • Tissue mineral density is normal and the radiographic density reflects prematurely formed bone occupying space that should still be cartilage
Refuting outcome
  • Bone tissue is genuinely hypermineralized, implying a mineralization defect additional to accelerated ossification
Show evidence (2 references)
PMID:8662561 SUPPORT Model Organism
"Most PTH/PTHrP receptor (-/-) mutant mice died in mid-gestation, a phenotype not observed in PTHrP (-/-) mice, perhaps because of the effects of maternal PTHrP."
The mid-gestation lethality that truncates the mouse skeletal phenotype is the basis of the mismatch.
PMID:35808914 SUPPORT Human Clinical
"X-rays of four fetuses evaluated postmortem showed advanced bone maturation, generalized osteosclerosis, and dumbbell-like appearance of long bones due to metaphyseal enlargement."
Documents the human radiographic osteosclerosis that the mouse literature does not report.
⚙

Pathophysiology

7
Biallelic PTH1R Loss-of-Function
PTH1R encodes the type 1 PTH/PTHrP receptor, a class B G protein-coupled receptor. Blomstrand alleles run from complete inactivation to near-complete inactivation with a low level of residual activity, and that difference is what the type I / type II division tracks. At the null end, a nonsense allele (R104X) truncates the receptor, and a splice-creating point mutation deletes the first 11 residues of the fifth transmembrane domain, yielding a receptor that reaches the cell surface but neither binds PTH or PTHrP nor generates cAMP or inositol phosphates. At the hypomorphic end, the recurrent P132L substitution in the N-terminal extracellular domain leaves surface expression intact but cripples ligand binding, and is assigned to the milder type II. The two laboratories that reported P132L in 1998 differ on how complete the defect is: one measured maximal specific radioligand binding at under 10 percent of wild type with severely reduced rather than absent cAMP, the other detected no binding and no cAMP at all. The 2007 functional re-analysis resolves this as low residual activity. Both alleles must be affected; heterozygous carrier parents are unaffected.
PTH1R hgnc:9608 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves PTH1R (hgnc:9608), qualified as loss of function. hgnc:9608 is a gene from the HUGO Gene Nomenclature Committee. ⇓ LOSS OF FUNCTION
Genetic context variant_origin: GERMLINE functional_impact_category: LOSS_OF_FUNCTION
Biallelic germline PTH1R alleles, reported both homozygous and compound heterozygous, with complete or near-complete loss of receptor function. `zygosity` is deliberately left unset: the cited source reports both homozygous and compound heterozygous genotypes, the slot is single-valued, and there is no biallelic permissible value, so asserting HOMOZYGOUS would narrow the claim past what the source supports.
PTH/PTHrP type 1 receptor activity GO:0004991 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves PTH/PTHrP type 1 receptor activity, annotated with parathyroid hormone receptor activity (GO:0004991), qualified as loss of function. GO:0004991 is a molecular function from the Gene Ontology. ⇓ LOSS OF FUNCTION
Downstream
Failure of PTH/PTHrP-Stimulated Signaling in Growth Plate Chondrocytes A receptor that cannot bind its ligands cannot transduce the PTHrP signal in chondrocytes, which is the immediate cellular consequence of the genotype.
Impaired PTHrP-Dependent Epithelial-Mesenchymal Signaling in Breast and Tooth The same receptor loss removes PTHrP signaling outside the growth plate, where it drives the epithelial-mesenchymal interactions that build the mammary gland and clear the eruption path of the tooth. This is the second, extraskeletal branch descending from the genotype.
Show evidence (7 references)
PMID:9649554 SUPPORT Human Clinical
"Analysis of PTH/PTHrP receptor cDNA demonstrated that: (a) this point mutation caused the deletion of the first 11 amino acids of exon M5 (encoding the fifth transmembrane domain of the receptor), resulting from the use of a novel splice site created by the base substitution;"
Identifies the molecular lesion in the index patient's PTH1R transcript.
PMID:9832466 SUPPORT Human Clinical
"A single homozygous nucleotide exchange in exon E3 of the gene encoding the parathyroid hormone receptor type 1 (PTHR1) was identified in an infant with Blomstrand chondrodysplasia born to consanguineous parents."
Independent identification of a homozygous inactivating PTH1R allele in an affected infant.
PMID:9745456 SUPPORT Human Clinical
"We describe a patient with Blomstrand chondrodysplasia, a lethal genetic disorder characterized by extremely advanced endochondral bone maturation, in whom a homozygous missense mutation is present in the gene coding for the PTH/PTHrP receptor that leads to the substitution of a proline for a..."
Reports the recurrent homozygous P132L allele in an affected patient.
+ 4 more references
Failure of PTH/PTHrP-Stimulated Signaling in Growth Plate Chondrocytes
PTHrP produced in the periarticular perichondrium normally acts on PTH1R borne by proliferating and prehypertrophic growth plate chondrocytes, raising cAMP and mobilizing inositol phosphates. In Blomstrand chondrodysplasia the receptor on the patient's own chondrocytes is non-functional, so this ligand-stimulated second messenger response is abolished. Loss of both the cAMP and the inositol phosphate arm has been demonstrated for the alleles recovered from affected fetuses.
growth plate chondrocyte CL:0000138 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves growth plate chondrocyte, annotated with chondrocyte (CL:0000138). CL:0000138 is a cell type from the Cell Ontology.
PTH1R-stimulated cAMP second messenger signaling GO:0007189 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased PTH1R-stimulated cAMP second messenger signaling, annotated with adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189). GO:0007189 is a biological process from the Gene Ontology. ↓ DECREASED
Animal models
PTH/PTHrP receptor null mouse Mus musculus recapitulates Explanted receptor-null bone is unresponsive to PTHrP and hedgehog, demonstrating in tissue the same signaling failure shown for human Blomstrand alleles in transfected cells.
Downstream
Loss of the Indian Hedgehog-PTHrP Brake on Chondrocyte Differentiation PTH1R is the effector arm of the Ihh-PTHrP feedback loop; abolishing receptor signaling disables the loop even though Ihh itself is intact.
Show evidence (3 references)
PMID:9745456 SUPPORT In Vitro
"PTH-induced cAMP accumulation was severely reduced in COS-7 cells expressing P132L receptors compared to that of cells expressing wild-type receptors, and PTH-induced inositol phosphate accumulation was not detectable in cells expressing the mutant receptor."
Quantifies the loss of both second messenger arms for the P132L Blomstrand allele.
PMID:9832466 SUPPORT In Vitro
"COS-1 cells expressing the mutant receptor did not accumulate cyclic adenosine 3',5'-monophosphate in response to PTH or PTH-related peptide (PTHrP) and did not bind the radiolabeled ligand."
Confirms abolished ligand binding and cAMP response for the same allele in an independent laboratory.
PMID:9832466 SUPPORT Human Clinical
"Expression of the mutant protein on the cell surface of transiently transfected COS-1 cells and in growth plate chondrocytes derived from the affected infant suggests that proline 132 is critical for the receptor's intrinsic binding activity."
Locates the defective receptor in the affected infant's own growth plate chondrocytes, tying the signaling failure to the relevant cell type in vivo.
Loss of the Indian Hedgehog-PTHrP Brake on Chondrocyte Differentiation
In the developing growth plate, prehypertrophic chondrocytes secrete Indian hedgehog, which induces PTHrP at the periarticular end; PTHrP in turn signals back through PTH1R to keep chondrocytes proliferating and to delay their exit into hypertrophy. The output of this loop is a negative regulation of chondrocyte differentiation. With PTH1R non-functional the loop has no effector, and the negative regulation is lost.
PTHrP-mediated negative regulation of chondrocyte differentiation GO:0032331 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves PTHrP-mediated negative regulation of chondrocyte differentiation, annotated with negative regulation of chondrocyte differentiation (GO:0032331), qualified as loss of function. GO:0032331 is a biological process from the Gene Ontology. ⇓ LOSS OF FUNCTION
Downstream
Accelerated Chondrocyte Hypertrophic Differentiation Removing the brake advances the timetable of chondrocyte differentiation.
Show evidence (2 references)
PMID:10912527 SUPPORT Other
"PTHrP is generated in response to Indian hedgehog (Ihh), which mediates its actions through the membrane receptor patched, but interacts also with hedgehog-interacting protein (Hip)."
States the Ihh-PTHrP relationship whose effector arm PTH1R provides.
PMID:8662561 SUPPORT Model Organism
"Mice that survived exhibited accelerated differentiation of chondrocytes in bone, and their bones, grown in explant culture, were resistant to the effects of PTHrP and Sonic hedgehog."
Receptor-null bone is refractory to both hedgehog and PTHrP, showing the loop cannot operate without PTH1R.
Accelerated Chondrocyte Hypertrophic Differentiation
Chondrocytes leave the proliferative pool early and pass into hypertrophy ahead of schedule. This is the defining cellular lesion of Blomstrand chondrodysplasia and is the exact inverse of Jansen metaphyseal chondrodysplasia, where constitutive PTH1R activity delays the same transition.
hypertrophic chondrocyte CL:0000743 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves hypertrophic chondrocyte (CL:0000743). CL:0000743 is a cell type from the Cell Ontology.
chondrocyte differentiation GO:0002062 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased chondrocyte differentiation (GO:0002062). GO:0002062 is a biological process from the Gene Ontology. ↑ INCREASED
Animal models
PTH/PTHrP receptor null mouse Mus musculus recapitulates Receptor-null mice show the same accelerated chondrocyte differentiation that defines the human condition, from the same molecular lesion (complete loss of PTH1R function).
Downstream
Growth Plate Hypoplasia and Disorganization Early exhaustion of the proliferative pool leaves a thin, disordered physis.
Premature and Advanced Endochondral Ossification Chondrocytes that hypertrophy early are replaced by bone early.
Show evidence (2 references)
PMID:27353973 SUPPORT Human Clinical
"Blomstrand osteochondrodysplasia (BOCD) is a rare autosomal recessive sclerosing skeletal dysplasia characterized by accelerated chondrocyte differentiation."
Names accelerated chondrocyte differentiation as the defining cellular feature of the human disease.
PMID:15525660 SUPPORT Human Clinical
"Notably, the skeletal features are opposite to those in Blomstrand chondrodysplasia, which is caused by inactivating recessive mutations in PTHR1."
Situates Blomstrand at the accelerated-maturation end of the PTH1R allelic series, opposite the delayed-maturation phenotypes.
Growth Plate Hypoplasia and Disorganization
Long bone histology in affected fetuses shows a narrow cartilaginous cap with severe hypoplasia and disorganization of both the proliferative and the hypertrophic zones. Because longitudinal growth is generated by the proliferative zone, its early exhaustion truncates limb elongation.
growth plate chondrocyte CL:0000138 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves growth plate chondrocyte, annotated with chondrocyte (CL:0000138). CL:0000138 is a cell type from the Cell Ontology.
Downstream
Severe micromelia Loss of the proliferative reserve that generates longitudinal growth produces extreme shortening of all four limbs.
Thoracic hypoplasia The ribs are endochondral bones that elongate at the same physes as the long bones, so the hypoplastic proliferative zone that truncates limb growth also truncates rib growth and leaves a small, narrow thorax in the same fetuses.
Show evidence (1 reference)
PMID:27353973 SUPPORT Human Clinical
"Histology of long bones revealed narrow cartilagenous cap and changes in the physeal growth zone which showed severe hypoplasia and disorganization of proliferative phase and hypertrophic phase."
Primary histological description of the growth plate lesion in three autopsy-confirmed fetuses.
Premature and Advanced Endochondral Ossification
Cartilage anlagen are converted to bone far ahead of gestational age, so ossification centres that should not yet be present are already mineralized and the skeleton reads as radiographically "mature" in a mid-gestation fetus. The same process produces a diffuse increase in bone density and the dumbbell-shaped, metaphyseally flared long bones seen on postmortem radiography.
endochondral ossification GO:0001958 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased endochondral ossification (GO:0001958). GO:0001958 is a biological process from the Gene Ontology. ↑ INCREASED
Downstream
Accelerated skeletal maturation Premature conversion of cartilage to bone is what "advanced skeletal maturation" measures radiographically.
Generalized osteosclerosis The excess of prematurely formed bone presents radiographically as a diffuse increase in density.
Dumbbell-shaped long bones with metaphyseal flaring Premature metaphyseal ossification and enlargement give the long bones their characteristic dumbbell outline.
Show evidence (1 reference)
PMID:35808914 SUPPORT Human Clinical
"X-rays of four fetuses evaluated postmortem showed advanced bone maturation, generalized osteosclerosis, and dumbbell-like appearance of long bones due to metaphyseal enlargement."
Postmortem radiographic confirmation of advanced ossification in four molecularly confirmed fetuses.
Impaired PTHrP-Dependent Epithelial-Mesenchymal Signaling in Breast and Tooth
PTHrP signaling through PTH1R is not confined to cartilage: in mice it also governs the epithelial-mesenchymal interactions that build the mammary gland and position the erupting tooth, and both PTHrP and PTH1R are expressed in the developing human breast and tooth. Loss of receptor function therefore produces extraskeletal developmental defects in the same fetuses, which is the most direct human evidence that this pathway is required outside the growth plate.
PTHrP-dependent epithelial-mesenchymal signaling in breast and tooth development GO:0071374 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves PTHrP-dependent epithelial-mesenchymal signaling in breast and tooth development, annotated with cellular response to parathyroid hormone stimulus (GO:0071374), qualified as loss of function. GO:0071374 is a biological process from the Gene Ontology. ⇓ LOSS OF FUNCTION
Downstream
Absent nipple The nipple fails to form without PTHrP-PTH1R signaling in the mammary bud.
Breast aplasia Mammary bud development fails without PTHrP-PTH1R signaling, so no breast tissue forms.
Impacted teeth Without PTH1R signaling the alveolar bone is not resorbed ahead of the erupting tooth, which becomes impacted and distorted.
Show evidence (1 reference)
PMID:11297619 SUPPORT Human Clinical
"Compatible with the involvement of PTHR1 and PTHrP in human breast and tooth morphogenesis, both were expressed within the developing breasts and teeth of normal human fetuses."
Establishes that the ligand and receptor are expressed at the affected sites in normal human fetal development.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Chondrodysplasia Blomstrand Type Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

15
Breast 2
Absent nipple HP:0002561 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Absent nipple (HP:0002561). HP:0002561 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:11297619 SUPPORT Human Clinical
"These fetuses lack nipples and breasts."
Direct autopsy observation in two Blomstrand fetuses.
Breast aplasia HP:0100783 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Breast aplasia (HP:0100783). HP:0100783 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:11297619 SUPPORT Human Clinical
"These fetuses lack nipples and breasts."
Direct autopsy observation in two Blomstrand fetuses.
Cardiovascular 1
Coarctation of the aorta Coarctation of aorta HP:0001680 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Coarctation of aorta (HP:0001680). HP:0001680 is a phenotype from the Human Phenotype Ontology.
No frequency band is asserted. The only cached source that states the association describes it as occurring "in some cases" and gives no numerator or denominator, and this entry has no cached primary case series that counts it. The phenotype is also left with no incoming causal edge: the same source says it is unclear whether PTH1R deficiency causes coarctation directly in humans, and the mechanism it proposes, Notch-dependent loss of aortic endothelium, was demonstrated in zebrafish morphants rather than in patients. Drawing the edge would assert a human causal claim the source declines to make.
Show evidence (1 reference)
DOI:10.1161/ATVBAHA.112.300590 SUPPORT Model Organism
"Blomstrand chondrodysplasia, caused by mutations in the parathyroid hormone receptor 1 (PTHR1) is associated with coarctation of the aorta in some cases, although it is unclear whether PTHR1 deficiency causes coarctation of the aorta directly."
States the human association and, in the same sentence, that its causal status is unresolved. Graded MODEL_ORGANISM because the cited publication is a zebrafish knockdown study; this sentence is its background summary of the human literature rather than a result of its own.
Head and Neck 4
Retro-micrognathia Retrognathia HP:0000278 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Retro-micrognathia, annotated with Retrognathia (HP:0000278). HP:0000278 is a phenotype from the Human Phenotype Ontology.
5 of 5 fetuses in the largest published series had retro-micrognathia on prenatal ultrasound. No FrequencyEnum band is asserted: a denominator of 5 cannot distinguish OBLIGATE from VERY_FREQUENT.
Sequelae: Protruding tongue
Show evidence (1 reference)
PMID:35808914 SUPPORT Human Clinical
"All fetuses presented with severe sonographic findings of LSDs comprising tetramicromelia, thoracic hypoplasia, and retro-micrognathia."
All five fetuses in the series had retro-micrognathia.
Protruding tongue HP:0010808 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Protruding tongue (HP:0010808). HP:0010808 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:35808914 SUPPORT Human Clinical
"The presence of retro-micrognathia along with a protruding tongue and severe metaphyseal flaring can suggest a diagnosis of BOCD, when prenatal ultrasound findings are indicative for LSD."
Names the protruding tongue as one of the three suggestive prenatal features.
Increased nuchal translucency HP:0010880 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Increased nuchal translucency (HP:0010880). HP:0010880 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27353973 SUPPORT Human Clinical
"Antenatal ultrasound findings include increased nuchal translucency, tetramicromelia and polyhydramnios."
Lists increased nuchal translucency among the antenatal findings.
Impacted teeth Impacted tooth HP:0011079 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Impacted tooth (HP:0011079). HP:0011079 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:11297619 SUPPORT Human Clinical
"Developing teeth were present, but they were severely impacted within the surrounding alveolar bone, leading to distortions in their architecture and orientation."
Direct autopsy observation of tooth impaction.
Limbs 2
Severe micromelia HP:0002983 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Tetramicromelia, annotated with Micromelia (HP:0002983). HP:0002983 is a phenotype from the Human Phenotype Ontology.
5 of 5 fetuses in the single largest published series presented with tetramicromelia on prenatal ultrasound. No FrequencyEnum band is asserted: the observed fraction is 100%, but a denominator of 5 cannot distinguish OBLIGATE from VERY_FREQUENT, and the series is a referred prenatal-diagnosis cohort rather than a complete ascertainment.
Show evidence (2 references)
PMID:35808914 SUPPORT Human Clinical
"All fetuses presented with severe sonographic findings of LSDs comprising tetramicromelia, thoracic hypoplasia, and retro-micrognathia."
All five fetuses in the series had tetramicromelia.
PMID:9268097 SUPPORT Human Clinical
"The hallmarks of this affection, also called Blomstrand chondrodysplasia, are short limbs, polyhydramnios, hydrops fetalis, facial anomalies, increased bone density, and a remarkable advance in skeletal maturation."
Lists short limbs among the hallmark features of the condition.
Dumbbell-shaped long bones with metaphyseal flaring Dumbbell-shaped metaphyses HP:0002810 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Dumbbell-shaped long bones, annotated with Dumbbell-shaped metaphyses (HP:0002810). HP:0002810 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:35808914 SUPPORT Human Clinical
"X-rays of four fetuses evaluated postmortem showed advanced bone maturation, generalized osteosclerosis, and dumbbell-like appearance of long bones due to metaphyseal enlargement."
Direct radiographic description of the dumbbell appearance and its metaphyseal basis.
PMID:35808914 SUPPORT Human Clinical
"The presence of retro-micrognathia along with a protruding tongue and severe metaphyseal flaring can suggest a diagnosis of BOCD, when prenatal ultrasound findings are indicative for LSD."
Identifies severe metaphyseal flaring as part of the diagnostic triad proposed by the authors.
Metabolism 1
Hydrops fetalis HP:0001789 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hydrops fetalis (HP:0001789). HP:0001789 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:9268097 SUPPORT Human Clinical
"The hallmarks of this affection, also called Blomstrand chondrodysplasia, are short limbs, polyhydramnios, hydrops fetalis, facial anomalies, increased bone density, and a remarkable advance in skeletal maturation."
Lists hydrops fetalis among the hallmark features.
Musculoskeletal 3
Accelerated skeletal maturation HP:0005616 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Accelerated skeletal maturation (HP:0005616). HP:0005616 is a phenotype from the Human Phenotype Ontology.
Advanced bone maturation was present on postmortem radiography in 4 of the 4 fetuses so evaluated in the largest published series. No FrequencyEnum band is asserted: a denominator of 4 cannot distinguish OBLIGATE from VERY_FREQUENT.
Show evidence (2 references)
PMID:10552065 SUPPORT Human Clinical
"The main findings in this lethal osteochondrodysplasia are osteosclerosis and advanced skeletal maturation."
Names advanced skeletal maturation as a cardinal finding.
PMID:10552065 SUPPORT Human Clinical
"Histopathological study of the bones confirmed the advanced skeletal maturation radiological features."
Histology confirms that the radiographic impression reflects true tissue-level advanced maturation.
Generalized osteosclerosis HP:0005789 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Generalized osteosclerosis (HP:0005789). HP:0005789 is a phenotype from the Human Phenotype Ontology.
Generalized osteosclerosis was present on postmortem radiography in 4 of the 4 fetuses so evaluated in the largest published series. No FrequencyEnum band is asserted: a denominator of 4 cannot distinguish OBLIGATE from VERY_FREQUENT.
Show evidence (1 reference)
PMID:35808914 SUPPORT Human Clinical
"X-rays of four fetuses evaluated postmortem showed advanced bone maturation, generalized osteosclerosis, and dumbbell-like appearance of long bones due to metaphyseal enlargement."
Radiographic documentation of generalized osteosclerosis in molecularly confirmed cases.
Thoracic hypoplasia HP:0005257 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Thoracic hypoplasia (HP:0005257). HP:0005257 is a phenotype from the Human Phenotype Ontology.
5 of 5 fetuses in the largest published series had thoracic hypoplasia on prenatal ultrasound. No FrequencyEnum band is asserted: a denominator of 5 cannot distinguish OBLIGATE from VERY_FREQUENT.
Sequelae: Perinatal lethality
Show evidence (1 reference)
PMID:35808914 SUPPORT Human Clinical
"All fetuses presented with severe sonographic findings of LSDs comprising tetramicromelia, thoracic hypoplasia, and retro-micrognathia."
All five fetuses in the series had thoracic hypoplasia.
Prenatal and Birth 1
Polyhydramnios HP:0001561 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Polyhydramnios (HP:0001561). HP:0001561 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:27353973 SUPPORT Human Clinical
"Antenatal ultrasound findings include increased nuchal translucency, tetramicromelia and polyhydramnios."
Lists polyhydramnios among the antenatal ultrasound findings.
PMID:9268097 SUPPORT Human Clinical
"The hallmarks of this affection, also called Blomstrand chondrodysplasia, are short limbs, polyhydramnios, hydrops fetalis, facial anomalies, increased bone density, and a remarkable advance in skeletal maturation."
Lists polyhydramnios among the hallmark features.
Other 1
Perinatal lethality OBLIGATE
Deliberately left unbound. HP:0003826 (Stillbirth) is the closest label match but is not a member of the PhenotypeTerm dynamic enum (it sits outside the Phenotypic abnormality subtree), and the mortality terms HP:0003811 (Neonatal death) and HP:0001522 (Death in infancy) are clinical-course modifiers rather than phenotypic abnormalities. Reported outcomes span both stillbirth (PMID:10552065) and perinatal death, so no single existing HPO phenotypic abnormality covers the claim; a wrong binding would be worse than none.
Show evidence (2 references)
PMID:35808914 SUPPORT Human Clinical
"Blomstrand osteochondrodysplasia (BOCD, MIM #215045) is an ultrarare lethal skeletal dysplasia (LSD) perinatally, characterized by extremely advanced bone maturation, generalized osteosclerosis, and severe tetramicromelia caused by biallelic loss-of-function mutations in the parathyroid hormone..."
States that the condition is perinatally lethal.
PMID:10552065 SUPPORT Human Clinical
"We report a female stillborn with typical clinical, radiological, and anatomopathological features of Blomstrand chondrodysplasia."
Documents stillbirth as the outcome in a phenotypically typical case.
🧬

Genetic Associations

1
PTH1R
Gene: PTH1R hgnc:9608 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is PTH1R (hgnc:9608). hgnc:9608 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE variant_origin: GERMLINE
Autosomal recessive
Show evidence (4 references)
PMID:35808914 SUPPORT Human Clinical
"Blomstrand osteochondrodysplasia (BOCD, MIM #215045) is an ultrarare lethal skeletal dysplasia (LSD) perinatally, characterized by extremely advanced bone maturation, generalized osteosclerosis, and severe tetramicromelia caused by biallelic loss-of-function mutations in the parathyroid hormone..."
Attributes the condition to biallelic loss-of-function PTH1R variants.
PMID:15525660 SUPPORT Human Clinical
"To our knowledge, this is the first description of opposite manifestations resulting from distinct recessive mutations in the same gene."
Documents that different recessive PTH1R alleles produce opposite skeletal phenotypes, the basis for the allelic-series note above.
DOI:10.1210/jc.2006-0300 SUPPORT Human Clinical
"In one of the type I BOCD cases, a homozygous nonsense mutation (R104X) was found, resulting in a truncated PTHR1."
The R104X allele added to the allelic spectrum above.
+ 1 more reference
💊

Medical Actions

2
Genetic counselling and recurrence-risk assessment
Action: Genetic CounselingNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Genetic Counseling (NCIT:C15240). NCIT:C15240 is a clinical intervention from the NCI Thesaurus. NCIT:C15240
Platform: Behavioral / lifestyle
There is no treatment for the fetus. The clinically actionable intervention is counselling the couple: a 25% recurrence risk per pregnancy, carrier testing where the causal PTH1R alleles are known, and the option of targeted molecular prenatal diagnosis or early anomaly scanning in a subsequent pregnancy. Recurrence in sibs is documented, so this is not a theoretical concern.
Show evidence (1 reference)
PMID:9268097 SUPPORT Human Clinical
"We report on two sibs with a rare lethal chondrodysplasia born to a non-consanguineous couple."
Documents sib recurrence in a non-consanguineous couple, which is what makes recurrence-risk counselling necessary.
Perinatal comfort and supportive care
Action: Supportive CareNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Supportive Care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. NCIT:C15747
Platform: Behavioral / lifestyle
For a liveborn infant, management is comfort-directed: the thorax cannot support ventilation and no intervention alters the outcome. Care is aimed at symptom relief and family support rather than at the disease.
Show evidence (1 reference)
PMID:35808914 SUPPORT INDIRECT Human Clinical
"Blomstrand osteochondrodysplasia (BOCD, MIM #215045) is an ultrarare lethal skeletal dysplasia (LSD) perinatally, characterized by extremely advanced bone maturation, generalized osteosclerosis, and severe tetramicromelia caused by biallelic loss-of-function mutations in the parathyroid hormone..."
The perinatally lethal course is what makes comfort-directed rather than disease-modifying care appropriate; no trial or guideline for supportive management of this specific condition exists, so this is an inference from the natural history.
🔬

Diagnosis

3
Prenatal ultrasound
Second-trimester ultrasound showing severe shortening of all four limbs with a hypoplastic thorax and retro-micrognathia establishes that a lethal skeletal dysplasia is present; a protruding tongue and severe metaphyseal flaring narrow that to Blomstrand osteochondrodysplasia.
Show evidence (1 reference)
PMID:35808914 SUPPORT Human Clinical
"The presence of retro-micrognathia along with a protruding tongue and severe metaphyseal flaring can suggest a diagnosis of BOCD, when prenatal ultrasound findings are indicative for LSD."
States the prenatal sonographic features that suggest this specific diagnosis.
Postmortem radiography and fetal autopsy
Babygram after delivery or termination shows advanced bone maturation, generalized osteosclerosis and dumbbell-shaped long bones; histology of the long bones shows the narrow cartilaginous cap and disorganized physis that confirm the diagnosis when molecular testing is unavailable.
Show evidence (1 reference)
PMID:27353973 SUPPORT Human Clinical
"In this article, we discuss three cases where lethal skeletal dysplasia was suspected and Blomstrand dysplasia was diagnosed by autopsy."
Establishes fetal autopsy as the diagnostic modality in three reported cases.
PTH1R sequencing
Identification of biallelic loss-of-function PTH1R variants confirms the diagnosis and is what makes accurate recurrence-risk counselling and subsequent prenatal testing possible.
Show evidence (1 reference)
PMID:35808914 SUPPORT Human Clinical
"The diagnosis can be ascertained through postmortem clinical and radiological evaluation and/or molecular testing."
States that molecular testing is a route to diagnostic confirmation.
📊

Prevalence

1
Worldwide
Unknown Ultra Rare
No population-based prevalence estimate exists. Blomstrand chondrodysplasia is described in the literature only as case reports and very small fetal series (the largest published series below comprises five fetuses collected over 19 years at a single prenatal diagnosis unit), and it is consistently characterized as "ultrarare". Because ascertainment depends on prenatal imaging followed by fetal autopsy and molecular confirmation, published counts are certainly an undercount; no numerator/denominator is available, so no numeric rate is asserted here.
Show evidence (1 reference)
PMID:35808914 SUPPORT Human Clinical
"Blomstrand osteochondrodysplasia (BOCD, MIM #215045) is an ultrarare lethal skeletal dysplasia (LSD) perinatally, characterized by extremely advanced bone maturation, generalized osteosclerosis, and severe tetramicromelia caused by biallelic loss-of-function mutations in the parathyroid hormone..."
Characterizes the condition as ultrarare, supporting the qualitative ULTRA_RARE band in the absence of a population estimate.
🔀

Differential Diagnoses

3

Conditions with similar clinical presentations that must be differentiated from Chondrodysplasia Blomstrand Type:

Jansen metaphyseal chondrodysplasia
Overlapping Features The other end of the PTH1R allelic series. Jansen is caused by heterozygous constitutively activating PTH1R variants and shows delayed, not accelerated, chondrocyte differentiation and endochondral ossification; it is compatible with survival to adulthood. The two conditions are radiographic mirror images and are distinguished by the direction of the skeletal maturation abnormality as well as by inheritance pattern.
Show evidence (1 reference)
PMID:9649554 SUPPORT Human Clinical
"abnormalities that are the mirror image of those observed in Jansen's chondrodysplasia"
States the mirror-image relationship between the two PTH1R disorders.
Eiken syndrome
Overlapping Features Also recessive and also PTH1R-related, but caused by truncation of the C-terminal cytoplasmic tail rather than by complete loss of ligand binding. Eiken syndrome is survivable and shows delayed ossification, the opposite skeletal direction to Blomstrand.
Show evidence (1 reference)
PMID:15525660 SUPPORT Human Clinical
"We identified a truncation mutation in the C-terminal cytoplasmic tail of the parathyroid hormone (PTH)/PTH-related peptide (PTHrP) type 1 receptor (PTHR1) gene as the cause of this syndrome."
Identifies the distinct Eiken allele class within the same gene.
Other lethal short-rib skeletal dysplasias
Overlapping Features Thanatophoric dysplasia, short-rib polydactyly syndromes and osteogenesis imperfecta type II all present prenatally with severe micromelia and a hypoplastic thorax. What separates Blomstrand from all of them is the direction of skeletal maturation: advanced ossification with generalized osteosclerosis rather than deficient or disordered mineralization.
Show evidence (1 reference)
PMID:35808914 SUPPORT Human Clinical
"We aim to describe prenatal ultrasonographic features in a retrospective fetal case series of BOCD and emphasize the importance of multidisciplinary antenatal evaluation of LSDs to improve the differential diagnosis."
Frames the case series explicitly as a contribution to the differential diagnosis of lethal skeletal dysplasias.
🐁

Animal Models

1
PTH/PTHrP receptor null mouse KNOCKOUT
Germline deletion of the murine PTH/PTHrP receptor. Most homozygotes die in mid-gestation; survivors show accelerated chondrocyte differentiation, and their bones are refractory to PTHrP and hedgehog in explant culture. This is the closest available model of the human disease and it reproduces both the cellular lesion and the lethality.
Species
Mus musculus
Genotype
Pth1r (PTH/PTHrP receptor) homozygous null, generated by homologous recombination
Genes
PTH1R hgnc:9608 HUGO Gene Nomenclature Committee (hgnc) Relation: this experimental model concerns this gene This experimental model concerns PTH1R (hgnc:9608). hgnc:9608 is a gene from the HUGO Gene Nomenclature Committee.
Publication
PMID:8662561
Pathograph links
Accelerated Chondrocyte Hypertrophic Differentiation recapitulates fidelity: high Receptor-null mice show the same accelerated chondrocyte differentiation that defines the human condition, from the same molecular lesion (complete loss of PTH1R function).
Limitations: The mouse is a complete germline null while human Blomstrand alleles are point mutations that leave a surface-expressed but signaling-dead receptor, and most null embryos die in mid-gestation before the skeletal phenotype can be fully assessed, so the surviving embryos are a selected subset. Radiographic osteosclerosis, the cardinal human finding, is not reported in this paper.
Readouts
Chondrocyte differentiation timing in developing bone
Direction: INCREASED
Interpretation: Accelerated differentiation in the receptor-null mouse is the direct cellular counterpart of the accelerated chondrocyte differentiation described in human Blomstrand autopsy histology.
Show evidence (1 reference)
PMID:8662561 SUPPORT Model Organism
"Mice that survived exhibited accelerated differentiation of chondrocytes in bone, and their bones, grown in explant culture, were resistant to the effects of PTHrP and Sonic hedgehog."
Reports the accelerated differentiation phenotype and the associated ligand resistance.
Show evidence (1 reference)
PMID:10912527 SUPPORT Model Organism
"Mice lacking PTHrP show accelerated chondrocyte differentiation, and thus premature ossification of those bones that are formed through an endochondral process, and similar but more-severe abnormalities are observed in PTH1R-ablated animals."
Independent review confirming that PTH1R ablation in mice reproduces (more severely) the accelerated-differentiation phenotype.
Failure of PTH/PTHrP-Stimulated Signaling in Growth Plate Chondrocytes recapitulates fidelity: high Explanted receptor-null bone is unresponsive to PTHrP and hedgehog, demonstrating in tissue the same signaling failure shown for human Blomstrand alleles in transfected cells.
Limitations: Responsiveness was assayed in explant culture rather than in vivo, and the hedgehog ligand used was Sonic rather than Indian hedgehog.
Readouts
Responsiveness of explanted bone to PTHrP and hedgehog
Direction: ABOLISHED
Interpretation: Loss of ligand responsiveness in receptor-null tissue is the tissue-level equivalent of the abolished cAMP and inositol phosphate response measured for Blomstrand alleles in transfected cells.
Show evidence (1 reference)
PMID:8662561 SUPPORT Model Organism
"Mice that survived exhibited accelerated differentiation of chondrocytes in bone, and their bones, grown in explant culture, were resistant to the effects of PTHrP and Sonic hedgehog."
Documents the loss of ligand responsiveness in receptor-null bone.
Show evidence (1 reference)
PMID:8662561 SUPPORT Model Organism
"These results suggest that the PTH/PTHrP receptor mediates the effects of Indian Hedgehog and PTHrP on chondrocyte differentiation."
Supports treating the receptor-null mouse as informative for the human signaling-failure node.
Show evidence (1 reference)
PMID:8662561 SUPPORT Model Organism
"Most PTH/PTHrP receptor (-/-) mutant mice died in mid-gestation, a phenotype not observed in PTHrP (-/-) mice, perhaps because of the effects of maternal PTHrP."
Establishes that receptor ablation, unlike ligand ablation, is embryonic-lethal in the mouse, paralleling the perinatal lethality of the human condition.
{ }

Source YAML

click to show 
name: Chondrodysplasia Blomstrand Type
creation_date: "2026-09-03T00:00:00Z"
category: Mendelian
description: >
  Blomstrand chondrodysplasia (Blomstrand osteochondrodysplasia, BOCD, MIM
  #215045) is an ultra-rare, perinatally lethal autosomal recessive
  osteochondrodysplasia caused by biallelic loss-of-function variants in PTH1R,
  the gene encoding the type 1 parathyroid hormone / parathyroid hormone-related
  peptide (PTH/PTHrP) receptor. In the normal growth plate, PTHrP acting through
  PTH1R holds chondrocytes in the proliferative pool and delays their exit into
  hypertrophy, as the distal limb of an Indian hedgehog-PTHrP negative feedback
  loop. When the receptor cannot bind ligand or generate a second messenger,
  that brake is removed: chondrocytes differentiate prematurely, the proliferative
  and hypertrophic zones become hypoplastic and disorganized, and endochondral
  ossification runs far ahead of gestational age. Affected fetuses show
  extremely advanced skeletal maturation, generalized osteosclerosis and severe
  tetramicromelia with dumbbell-shaped, metaphyseally flared long bones,
  together with polyhydramnios, hydrops fetalis, thoracic hypoplasia and a
  characteristic face with retro-micrognathia and a protruding tongue. Because
  PTHrP-PTH1R signaling also drives epithelial-mesenchymal interactions outside
  the skeleton, affected fetuses additionally lack nipples and breasts and have
  severely impacted teeth. The condition is uniformly lethal in utero or shortly
  after birth. It is divided by skeletal severity into type I, caused by complete
  inactivation of PTH1R, and the milder type II, in which a near-complete
  inactivation leaves a low level of residual receptor activity; both are lethal.
  It is the mechanistic mirror image of Jansen metaphyseal
  chondrodysplasia, in which constitutively activating PTH1R variants delay
  chondrocyte differentiation.
disease_term:
  preferred_term: Blomstrand osteochondrodysplasia
  term:
    id: MONDO:0008970
    label: chondrodysplasia Blomstrand type
parents:
- Skeletal disorder of parathyroid hormone signaling
- Lethal osteochondrodysplasia
synonyms:
- Blomstrand chondrodysplasia
- Blomstrand lethal chondrodysplasia
- Blomstrand lethal osteochondrodysplasia
- Blomstrand osteochondrodysplasia
- BOCD
- BLC
classifications:
  isds_skeletal_category:
  - classification_value: parathyroid_hormone_signaling
    notes: >-
      ISDS Nosology of Genetic Skeletal Disorders, 2023 revision (11th edition;
      Unger et al., PMID:36779427), group 28 "Skeletal disorders of parathyroid
      hormone signaling cascade", which lists "Blomstrand dysplasia (PTH1R)" as a
      member. The 2019 revision placed Blomstrand in the neonatal osteosclerotic
      dysplasia group; the 2023 table moved it into the new PTH-signaling group
      alongside the other PTH1R disorders (Jansen and Eiken).
inheritance:
- name: Autosomal recessive
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  description: >
    Blomstrand chondrodysplasia segregates as an autosomal recessive trait.
    Affected fetuses carry homozygous or compound heterozygous PTH1R alleles;
    parental consanguinity and recurrence of the phenotype in sibs of both sexes
    born to unaffected parents were the original evidence for recessive
    inheritance, and have since been confirmed molecularly.
  evidence:
  - reference: PMID:10552065
    reference_title: "Blomstrand chondrodysplasia: a lethal sclerosing skeletal dysplasia. Case report and review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Autosomal recessive inheritance has been proposed because of parental consanguinity of affected siblings in all reported cases, including this one."
    explanation: States the consanguinity/sib-recurrence basis for recessive inheritance across the reported case series.
  - reference: PMID:9268097
    reference_title: "Familial Blomstrand chondrodysplasia with advanced skeletal maturation: further delineation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "This recurrence affecting a male and a female fetus, born to the same couple, suggests autosomal recessive inheritance."
    explanation: Recurrence in a male and a female sib of unaffected parents demonstrates autosomal rather than X-linked recessive transmission.
  - reference: PMID:27353973
    reference_title: "Usefulness of fetal autopsy in the diagnosis of blomstrand chondrodysplasia: a report of three cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Homozygous and compound heterozygous mutations in PTHR1 gene have been implicated in the pathogenesis of this chondrodysplasia."
    explanation: Confirms that the causal PTH1R genotypes are biallelic (homozygous or compound heterozygous).
has_subtypes:
- name: Type I
  display_name: BOCD type I (complete PTH1R inactivation)
  description: >
    The severe form, in which the PTH1R allele is completely inactivated and no
    receptor activity remains. The reported type I allele is a homozygous
    nonsense substitution, R104X, which truncates the receptor. Type I is the
    more severe end of the skeletal spectrum on which the two-type division of
    Blomstrand osteochondrodysplasia is based; the division is by severity of the
    skeletal abnormalities, and the molecular correlate is how much residual
    receptor activity survives.
  evidence:
  - reference: DOI:10.1210/jc.2006-0300
    reference_title: "Novel Mutations in the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Type 1 Causing Blomstrand Osteochondrodysplasia Types I and II"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "BOCD can be divided into two types, depending on the severity of the skeletal abnormalities."
    explanation: States that the disease is divided into two types on skeletal severity, which is the basis for these subtype entries.
  - reference: DOI:10.1210/jc.2006-0300
    reference_title: "Novel Mutations in the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Type 1 Causing Blomstrand Osteochondrodysplasia Types I and II"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In one of the type I BOCD cases, a homozygous nonsense mutation (R104X) was found, resulting in a truncated PTHR1."
    explanation: Supplies the allelic anchor for type I.
  - reference: DOI:10.1210/jc.2006-0300
    reference_title: "Novel Mutations in the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Type 1 Causing Blomstrand Osteochondrodysplasia Types I and II"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In combination with data presented in literature, we conclude that type I BOCD is caused by a complete inactivation of the PTHR1, whereas low levels of residual activity due to a near complete inactivation of the PTHR1 result in the relatively milder presentation of type II BOCD."
    explanation: States the molecular basis assigned to type I, complete receptor inactivation.
  review_notes: >
    In the second type I family reported by Hoogendam et al. no PTH1R mutation
    was found, so the type I group is defined clinically and is not fully
    accounted for at the molecular level.
- name: Type II
  display_name: BOCD type II (near-complete PTH1R inactivation with residual activity)
  description: >
    The relatively milder form, in which the receptor is not completely
    inactivated and a low level of residual activity survives. Two type II
    alleles are described: a homozygous intronic substitution that creates a
    novel splice site preferentially used in patient dermal fibroblasts, while
    the wild-type transcript persists at low levels; and the recurrent
    homozygous P132L missense substitution, which functional analysis shows to
    retain low residual activity. Type II is still perinatally lethal; the
    contrast with type I is in the severity of the skeletal abnormalities, not
    in survival.
  evidence:
  - reference: DOI:10.1210/jc.2006-0300
    reference_title: "Novel Mutations in the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Type 1 Causing Blomstrand Osteochondrodysplasia Types I and II"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We performed mutation analysis in two families with type I and in three families with the less severe form of BOCD type II."
    explanation: Establishes type II as the less severe form and the families in which it was characterised.
  - reference: DOI:10.1210/jc.2006-0300
    reference_title: "Novel Mutations in the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Type 1 Causing Blomstrand Osteochondrodysplasia Types I and II"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In the other two families with type II BOCD, a previously identified homozygous missense mutation (P132L) was found."
    explanation: Assigns the recurrent P132L allele to type II.
  - reference: DOI:10.1210/jc.2006-0300
    reference_title: "Novel Mutations in the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Type 1 Causing Blomstrand Osteochondrodysplasia Types I and II"
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Functional analysis demonstrated that the P132L mutant had low residual activity."
    explanation: The functional result that places P132L in the near-complete-inactivation group rather than the null group.
  - reference: DOI:10.1210/jc.2006-0300
    reference_title: "Novel Mutations in the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Type 1 Causing Blomstrand Osteochondrodysplasia Types I and II"
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "In dermal fibroblasts of the patient, this novel splice site was preferentially used, resulting in an aberrant transcript. The wild-type transcript remained, however, present, albeit at low levels."
    explanation: Shows the residual wild-type transcript that is the molecular basis for the milder type II presentation of the intronic allele.
  review_notes: >
    No subtype-specific frequency is asserted. Hoogendam et al. studied two type
    I and three type II families; that is a series, not a denominator for the
    disease, and no other cached source stratifies reported cases by type.

prevalence:
- population: Worldwide
  measure_type: UNKNOWN
  prevalence_class: ULTRA_RARE
  notes: >
    No population-based prevalence estimate exists. Blomstrand chondrodysplasia
    is described in the literature only as case reports and very small fetal
    series (the largest published series below comprises five fetuses collected
    over 19 years at a single prenatal diagnosis unit), and it is consistently
    characterized as "ultrarare". Because ascertainment depends on prenatal
    imaging followed by fetal autopsy and molecular confirmation, published
    counts are certainly an undercount; no numerator/denominator is available,
    so no numeric rate is asserted here.
  evidence:
  - reference: PMID:35808914
    reference_title: "Prenatal ultrasonographic features in Blomstrand osteochondrodysplasia: Antenatal case series confirmed by postmortem radiology and molecular diagnosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Blomstrand osteochondrodysplasia (BOCD, MIM #215045) is an ultrarare lethal skeletal dysplasia (LSD) perinatally, characterized by extremely advanced bone maturation, generalized osteosclerosis, and severe tetramicromelia caused by biallelic loss-of-function mutations in the parathyroid hormone receptor-1 gene (PTHR1)."
    explanation: Characterizes the condition as ultrarare, supporting the qualitative ULTRA_RARE band in the absence of a population estimate.
pathophysiology:
- name: Biallelic PTH1R Loss-of-Function
  biological_scale: MOLECULAR
  description: >
    PTH1R encodes the type 1 PTH/PTHrP receptor, a class B G protein-coupled
    receptor. Blomstrand alleles run from complete inactivation to near-complete
    inactivation with a low level of residual activity, and that difference is
    what the type I / type II division tracks. At the null end, a nonsense allele
    (R104X) truncates the receptor, and a splice-creating point mutation deletes
    the first 11 residues of the fifth transmembrane domain, yielding a receptor
    that reaches the cell surface but neither binds PTH or PTHrP nor generates
    cAMP or inositol phosphates. At the hypomorphic end, the recurrent P132L
    substitution in the N-terminal extracellular domain leaves surface expression
    intact but cripples ligand binding, and is assigned to the milder type II.
    The two laboratories that reported P132L in 1998 differ on how complete the
    defect is: one measured maximal specific radioligand binding at under 10
    percent of wild type with severely reduced rather than absent cAMP, the other
    detected no binding and no cAMP at all. The 2007 functional re-analysis
    resolves this as low residual activity. Both alleles must be affected;
    heterozygous carrier parents are unaffected.
  genetic_context:
    functional_impact_category: LOSS_OF_FUNCTION
    variant_origin: GERMLINE
    description: >-
      Biallelic germline PTH1R alleles, reported both homozygous and compound
      heterozygous, with complete or near-complete loss of receptor function.
      `zygosity` is deliberately left unset: the cited source reports both
      homozygous and compound heterozygous genotypes, the slot is single-valued,
      and there is no biallelic permissible value, so asserting HOMOZYGOUS would
      narrow the claim past what the source supports.
  gene:
    preferred_term: PTH1R
    modifier: LOSS_OF_FUNCTION
    term:
      id: hgnc:9608
      label: PTH1R
  molecular_functions:
  - preferred_term: PTH/PTHrP type 1 receptor activity
    modifier: LOSS_OF_FUNCTION
    term:
      id: GO:0004991
      label: parathyroid hormone receptor activity
  downstream:
  - target: Failure of PTH/PTHrP-Stimulated Signaling in Growth Plate Chondrocytes
    description: >
      A receptor that cannot bind its ligands cannot transduce the PTHrP signal
      in chondrocytes, which is the immediate cellular consequence of the
      genotype.
    evidence:
    - reference: PMID:9649554
      reference_title: Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia.
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "the mutant receptor was well expressed in COS-7 cells, but did not bind PTH or PTHrP, and failed to induce detectable stimulation of either cAMP or inositol phosphate production in response to these ligands"
      explanation: Directly demonstrates that the patient's allele produces a surface-expressed but signaling-dead receptor.
  - target: Impaired PTHrP-Dependent Epithelial-Mesenchymal Signaling in Breast and Tooth
    description: >
      The same receptor loss removes PTHrP signaling outside the growth plate,
      where it drives the epithelial-mesenchymal interactions that build the
      mammary gland and clear the eruption path of the tooth. This is the second,
      extraskeletal branch descending from the genotype.
    evidence:
    - reference: PMID:11297619
      reference_title: Absence of functional type 1 parathyroid hormone (PTH)/PTH-related protein receptors in humans is associated with abnormal breast development and tooth impaction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Therefore, impairment of the PTHrP/PTHR1 signaling pathway in humans is associated with severe abnormalities in tooth and breast development."
      explanation: States that loss of PTHrP/PTHR1 signaling in humans produces the breast and tooth developmental defects, which is the edge from the genotype to this extraskeletal node.
  evidence:
  - reference: PMID:9649554
    reference_title: Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Analysis of PTH/PTHrP receptor cDNA demonstrated that: (a) this point mutation caused the deletion of the first 11 amino acids of exon M5 (encoding the fifth transmembrane domain of the receptor), resulting from the use of a novel splice site created by the base substitution;"
    explanation: Identifies the molecular lesion in the index patient's PTH1R transcript.
  - reference: PMID:9832466
    reference_title: Inactivating mutation in the human parathyroid hormone receptor type 1 gene in Blomstrand chondrodysplasia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A single homozygous nucleotide exchange in exon E3 of the gene encoding the parathyroid hormone receptor type 1 (PTHR1) was identified in an infant with Blomstrand chondrodysplasia born to consanguineous parents."
    explanation: Independent identification of a homozygous inactivating PTH1R allele in an affected infant.
  - reference: PMID:9745456
    reference_title: A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We describe a patient with Blomstrand chondrodysplasia, a lethal genetic disorder characterized by extremely advanced endochondral bone maturation, in whom a homozygous missense mutation is present in the gene coding for the PTH/PTHrP receptor that leads to the substitution of a proline for a leucine in the N-terminal portion of the receptor (P132L)."
    explanation: Reports the recurrent homozygous P132L allele in an affected patient.
  - reference: PMID:9745456
    reference_title: A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "by cells transfected with the P132L receptor was < 10% of that observed for cells transfected with the wild-type receptor."
    explanation: >-
      Reports maximal specific binding of radioiodinated PTHrP(1-36) at under 10
      percent of wild type, which is a severe but not absolute binding defect,
      and is why this node no longer describes every Blomstrand allele as
      abolishing function outright. The quote is trimmed to start after the
      bracketed radioligand designation because the reference validator strips
      bracketed spans that do not match its literal patterns.
  - reference: PMID:9745456
    reference_title: A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Despite the reduction in radioligand binding to P132L receptors, the intensity and distribution of the fluorescent signal resulting from the expression of receptors fused to GFP were similar for cells transfected with the wild-type and mutant P132L receptors, suggesting a similar degree of cell surface expression."
    explanation: Shows that P132L reaches the cell surface normally, so the defect is in ligand binding rather than trafficking.
  - reference: DOI:10.1210/jc.2006-0300
    reference_title: "Novel Mutations in the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Type 1 Causing Blomstrand Osteochondrodysplasia Types I and II"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In combination with data presented in literature, we conclude that type I BOCD is caused by a complete inactivation of the PTHR1, whereas low levels of residual activity due to a near complete inactivation of the PTHR1 result in the relatively milder presentation of type II BOCD."
    explanation: The genotype-severity axis this node now describes, separating complete inactivation from near-complete inactivation with residual activity.
  - reference: DOI:10.1210/jc.2006-0300
    reference_title: "Novel Mutations in the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Type 1 Causing Blomstrand Osteochondrodysplasia Types I and II"
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Functional analysis demonstrated that the P132L mutant had low residual activity."
    explanation: The functional result that places the recurrent allele at the hypomorphic rather than the null end.
- name: Failure of PTH/PTHrP-Stimulated Signaling in Growth Plate Chondrocytes
  biological_scale: CELLULAR
  description: >
    PTHrP produced in the periarticular perichondrium normally acts on PTH1R
    borne by proliferating and prehypertrophic growth plate chondrocytes,
    raising cAMP and mobilizing inositol phosphates. In Blomstrand
    chondrodysplasia the receptor on the patient's own chondrocytes is
    non-functional, so this ligand-stimulated second messenger response is
    abolished. Loss of both the cAMP and the inositol phosphate arm has been
    demonstrated for the alleles recovered from affected fetuses.
  cell_types:
  - preferred_term: growth plate chondrocyte
    term:
      id: CL:0000138
      label: chondrocyte
  biological_processes:
  - preferred_term: PTH1R-stimulated cAMP second messenger signaling
    modifier: DECREASED
    term:
      id: GO:0007189
      label: adenylate cyclase-activating G protein-coupled receptor signaling pathway
  downstream:
  - target: Loss of the Indian Hedgehog-PTHrP Brake on Chondrocyte Differentiation
    description: >
      PTH1R is the effector arm of the Ihh-PTHrP feedback loop; abolishing
      receptor signaling disables the loop even though Ihh itself is intact.
    evidence:
    - reference: PMID:8662561
      reference_title: PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "These results suggest that the PTH/PTHrP receptor mediates the effects of Indian Hedgehog and PTHrP on chondrocyte differentiation."
      explanation: Establishes PTH1R as the receptor through which both Ihh and PTHrP act on chondrocyte differentiation, so its loss breaks the loop.
  evidence:
  - reference: PMID:9745456
    reference_title: A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "PTH-induced cAMP accumulation was severely reduced in COS-7 cells expressing P132L receptors compared to that of cells expressing wild-type receptors, and PTH-induced inositol phosphate accumulation was not detectable in cells expressing the mutant receptor."
    explanation: Quantifies the loss of both second messenger arms for the P132L Blomstrand allele.
  - reference: PMID:9832466
    reference_title: Inactivating mutation in the human parathyroid hormone receptor type 1 gene in Blomstrand chondrodysplasia.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "COS-1 cells expressing the mutant receptor did not accumulate cyclic adenosine 3',5'-monophosphate in response to PTH or PTH-related peptide (PTHrP) and did not bind the radiolabeled ligand."
    explanation: Confirms abolished ligand binding and cAMP response for the same allele in an independent laboratory.
  - reference: PMID:9832466
    reference_title: Inactivating mutation in the human parathyroid hormone receptor type 1 gene in Blomstrand chondrodysplasia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Expression of the mutant protein on the cell surface of transiently transfected COS-1 cells and in growth plate chondrocytes derived from the affected infant suggests that proline 132 is critical for the receptor's intrinsic binding activity."
    explanation: Locates the defective receptor in the affected infant's own growth plate chondrocytes, tying the signaling failure to the relevant cell type in vivo.
- name: Loss of the Indian Hedgehog-PTHrP Brake on Chondrocyte Differentiation
  biological_scale: CELLULAR
  description: >
    In the developing growth plate, prehypertrophic chondrocytes secrete Indian
    hedgehog, which induces PTHrP at the periarticular end; PTHrP in turn signals
    back through PTH1R to keep chondrocytes proliferating and to delay their exit
    into hypertrophy. The output of this loop is a negative regulation of
    chondrocyte differentiation. With PTH1R non-functional the loop has no
    effector, and the negative regulation is lost.
  biological_processes:
  - preferred_term: PTHrP-mediated negative regulation of chondrocyte differentiation
    modifier: LOSS_OF_FUNCTION
    term:
      id: GO:0032331
      label: negative regulation of chondrocyte differentiation
  downstream:
  - target: Accelerated Chondrocyte Hypertrophic Differentiation
    description: >
      Removing the brake advances the timetable of chondrocyte differentiation.
    evidence:
    - reference: PMID:10912527
      reference_title: Role of parathyroid hormone-related peptide and Indian hedgehog in skeletal development.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Mice lacking PTHrP show accelerated chondrocyte differentiation, and thus premature ossification of those bones that are formed through an endochondral process, and similar but more-severe abnormalities are observed in PTH1R-ablated animals."
      explanation: Ablating either the ligand or the receptor accelerates chondrocyte differentiation, establishing the direction of the causal edge.
  evidence:
  - reference: PMID:10912527
    reference_title: Role of parathyroid hormone-related peptide and Indian hedgehog in skeletal development.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "PTHrP is generated in response to Indian hedgehog (Ihh), which mediates its actions through the membrane receptor patched, but interacts also with hedgehog-interacting protein (Hip)."
    explanation: States the Ihh-PTHrP relationship whose effector arm PTH1R provides.
  - reference: PMID:8662561
    reference_title: PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Mice that survived exhibited accelerated differentiation of chondrocytes in bone, and their bones, grown in explant culture, were resistant to the effects of PTHrP and Sonic hedgehog."
    explanation: Receptor-null bone is refractory to both hedgehog and PTHrP, showing the loop cannot operate without PTH1R.
- name: Accelerated Chondrocyte Hypertrophic Differentiation
  biological_scale: CELLULAR
  description: >
    Chondrocytes leave the proliferative pool early and pass into hypertrophy
    ahead of schedule. This is the defining cellular lesion of Blomstrand
    chondrodysplasia and is the exact inverse of Jansen metaphyseal
    chondrodysplasia, where constitutive PTH1R activity delays the same
    transition.
  cell_types:
  - preferred_term: hypertrophic chondrocyte
    term:
      id: CL:0000743
      label: hypertrophic chondrocyte
  biological_processes:
  - preferred_term: chondrocyte differentiation
    modifier: INCREASED
    term:
      id: GO:0002062
      label: chondrocyte differentiation
  downstream:
  - target: Growth Plate Hypoplasia and Disorganization
    description: >
      Early exhaustion of the proliferative pool leaves a thin, disordered
      physis.
    evidence:
    - reference: PMID:27353973
      reference_title: "Usefulness of fetal autopsy in the diagnosis of blomstrand chondrodysplasia: a report of three cases."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Histology of long bones revealed narrow cartilagenous cap and changes in the physeal growth zone which showed severe hypoplasia and disorganization of proliferative phase and hypertrophic phase."
      explanation: Fetal autopsy histology shows the hypoplastic, disorganized physis that follows accelerated differentiation.
  - target: Premature and Advanced Endochondral Ossification
    description: >
      Chondrocytes that hypertrophy early are replaced by bone early.
    evidence:
    - reference: PMID:10912527
      reference_title: Role of parathyroid hormone-related peptide and Indian hedgehog in skeletal development.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Mice lacking PTHrP show accelerated chondrocyte differentiation, and thus premature ossification of those bones that are formed through an endochondral process, and similar but more-severe abnormalities are observed in PTH1R-ablated animals."
      explanation: Explicitly links accelerated chondrocyte differentiation to premature endochondral ossification.
  evidence:
  - reference: PMID:27353973
    reference_title: "Usefulness of fetal autopsy in the diagnosis of blomstrand chondrodysplasia: a report of three cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Blomstrand osteochondrodysplasia (BOCD) is a rare autosomal recessive sclerosing skeletal dysplasia characterized by accelerated chondrocyte differentiation."
    explanation: Names accelerated chondrocyte differentiation as the defining cellular feature of the human disease.
  - reference: PMID:15525660
    reference_title: Recessive mutations in PTHR1 cause contrasting skeletal dysplasias in Eiken and Blomstrand syndromes.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Notably, the skeletal features are opposite to those in Blomstrand chondrodysplasia, which is caused by inactivating recessive mutations in PTHR1."
    explanation: Situates Blomstrand at the accelerated-maturation end of the PTH1R allelic series, opposite the delayed-maturation phenotypes.
- name: Growth Plate Hypoplasia and Disorganization
  biological_scale: TISSUE
  description: >
    Long bone histology in affected fetuses shows a narrow cartilaginous cap
    with severe hypoplasia and disorganization of both the proliferative and the
    hypertrophic zones. Because longitudinal growth is generated by the
    proliferative zone, its early exhaustion truncates limb elongation.
  cell_types:
  - preferred_term: growth plate chondrocyte
    term:
      id: CL:0000138
      label: chondrocyte
  downstream:
  - target: Severe micromelia
    description: >
      Loss of the proliferative reserve that generates longitudinal growth
      produces extreme shortening of all four limbs.
    evidence:
    - reference: PMID:9832466
      reference_title: Inactivating mutation in the human parathyroid hormone receptor type 1 gene in Blomstrand chondrodysplasia.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "These findings suggest that the Blomstrand form of human short-limbed dwarfism arises from defective PTHR1 signaling in the developing cartilaginous skeleton."
      explanation: Attributes the short-limbed phenotype specifically to defective PTH1R signaling in cartilage.
  - target: Thoracic hypoplasia
    description: >
      The ribs are endochondral bones that elongate at the same physes as the
      long bones, so the hypoplastic proliferative zone that truncates limb
      growth also truncates rib growth and leaves a small, narrow thorax in the
      same fetuses.
    evidence:
    - reference: PMID:9832466
      reference_title: Inactivating mutation in the human parathyroid hormone receptor type 1 gene in Blomstrand chondrodysplasia.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "These findings suggest that the Blomstrand form of human short-limbed dwarfism arises from defective PTHR1 signaling in the developing cartilaginous skeleton."
      explanation: >
        Locates the lesion in the developing cartilaginous skeleton as a whole
        rather than in the limbs alone. The ribs grow at the same physes, so the
        thoracic consequence follows by that inference step; no reported study
        measures rib length or physeal histology in the ribs of these fetuses.
      directness: INDIRECT
    - reference: PMID:35808914
      reference_title: "Prenatal ultrasonographic features in Blomstrand osteochondrodysplasia: Antenatal case series confirmed by postmortem radiology and molecular diagnosis."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "All fetuses presented with severe sonographic findings of LSDs comprising tetramicromelia, thoracic hypoplasia, and retro-micrognathia."
      explanation: >
        Thoracic hypoplasia and tetramicromelia were present together in all five
        fetuses of the largest series, which is co-occurrence within one
        generalized endochondral dysplasia rather than a demonstrated cause and
        effect.
      directness: INDIRECT
  evidence:
  - reference: PMID:27353973
    reference_title: "Usefulness of fetal autopsy in the diagnosis of blomstrand chondrodysplasia: a report of three cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Histology of long bones revealed narrow cartilagenous cap and changes in the physeal growth zone which showed severe hypoplasia and disorganization of proliferative phase and hypertrophic phase."
    explanation: Primary histological description of the growth plate lesion in three autopsy-confirmed fetuses.
- name: Premature and Advanced Endochondral Ossification
  biological_scale: TISSUE
  description: >
    Cartilage anlagen are converted to bone far ahead of gestational age, so
    ossification centres that should not yet be present are already mineralized
    and the skeleton reads as radiographically "mature" in a mid-gestation fetus.
    The same process produces a diffuse increase in bone density and the
    dumbbell-shaped, metaphyseally flared long bones seen on postmortem
    radiography.
  biological_processes:
  - preferred_term: endochondral ossification
    modifier: INCREASED
    term:
      id: GO:0001958
      label: endochondral ossification
  downstream:
  - target: Accelerated skeletal maturation
    description: >
      Premature conversion of cartilage to bone is what "advanced skeletal
      maturation" measures radiographically.
    evidence:
    - reference: PMID:9649554
      reference_title: Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "We report the absence of functional parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptors (PTH/PTHrP receptor) in Blomstrand chondrodysplasia, a genetic disorder characterized by advanced endochondral bone maturation."
      explanation: Defines the disease by advanced endochondral bone maturation and attributes it to absent receptor function.
  - target: Generalized osteosclerosis
    description: >
      The excess of prematurely formed bone presents radiographically as a
      diffuse increase in density.
    evidence:
    - reference: PMID:10552065
      reference_title: "Blomstrand chondrodysplasia: a lethal sclerosing skeletal dysplasia. Case report and review."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The main findings in this lethal osteochondrodysplasia are osteosclerosis and advanced skeletal maturation."
      explanation: Pairs osteosclerosis with advanced maturation as the two cardinal findings of the same process.
  - target: Dumbbell-shaped long bones with metaphyseal flaring
    description: >
      Premature metaphyseal ossification and enlargement give the long bones
      their characteristic dumbbell outline.
    evidence:
    - reference: PMID:35808914
      reference_title: "Prenatal ultrasonographic features in Blomstrand osteochondrodysplasia: Antenatal case series confirmed by postmortem radiology and molecular diagnosis."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "X-rays of four fetuses evaluated postmortem showed advanced bone maturation, generalized osteosclerosis, and dumbbell-like appearance of long bones due to metaphyseal enlargement."
      explanation: Attributes the dumbbell appearance to metaphyseal enlargement in the same radiographs that show advanced maturation.
  evidence:
  - reference: PMID:35808914
    reference_title: "Prenatal ultrasonographic features in Blomstrand osteochondrodysplasia: Antenatal case series confirmed by postmortem radiology and molecular diagnosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "X-rays of four fetuses evaluated postmortem showed advanced bone maturation, generalized osteosclerosis, and dumbbell-like appearance of long bones due to metaphyseal enlargement."
    explanation: Postmortem radiographic confirmation of advanced ossification in four molecularly confirmed fetuses.
- name: Impaired PTHrP-Dependent Epithelial-Mesenchymal Signaling in Breast and Tooth
  biological_scale: TISSUE
  description: >
    PTHrP signaling through PTH1R is not confined to cartilage: in mice it also
    governs the epithelial-mesenchymal interactions that build the mammary gland
    and position the erupting tooth, and both PTHrP and PTH1R are expressed in
    the developing human breast and tooth. Loss of receptor function therefore
    produces extraskeletal developmental defects in the same fetuses, which is
    the most direct human evidence that this pathway is required outside the
    growth plate.
  biological_processes:
  - preferred_term: PTHrP-dependent epithelial-mesenchymal signaling in breast and tooth development
    modifier: LOSS_OF_FUNCTION
    term:
      id: GO:0071374
      label: cellular response to parathyroid hormone stimulus
  downstream:
  - target: Absent nipple
    description: >
      The nipple fails to form without PTHrP-PTH1R signaling in the mammary bud.
    evidence:
    - reference: PMID:11297619
      reference_title: Absence of functional type 1 parathyroid hormone (PTH)/PTH-related protein receptors in humans is associated with abnormal breast development and tooth impaction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "These fetuses lack nipples and breasts."
      explanation: Direct observation of absent nipples in two Blomstrand fetuses.
  - target: Breast aplasia
    description: >
      Mammary bud development fails without PTHrP-PTH1R signaling, so no breast
      tissue forms.
    evidence:
    - reference: PMID:11297619
      reference_title: Absence of functional type 1 parathyroid hormone (PTH)/PTH-related protein receptors in humans is associated with abnormal breast development and tooth impaction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "These fetuses lack nipples and breasts."
      explanation: Direct observation of absent breast development in two Blomstrand fetuses.
  - target: Impacted teeth
    description: >
      Without PTH1R signaling the alveolar bone is not resorbed ahead of the
      erupting tooth, which becomes impacted and distorted.
    evidence:
    - reference: PMID:11297619
      reference_title: Absence of functional type 1 parathyroid hormone (PTH)/PTH-related protein receptors in humans is associated with abnormal breast development and tooth impaction.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Developing teeth were present, but they were severely impacted within the surrounding alveolar bone, leading to distortions in their architecture and orientation."
      explanation: Direct observation of tooth impaction in the same fetuses.
  evidence:
  - reference: PMID:11297619
    reference_title: Absence of functional type 1 parathyroid hormone (PTH)/PTH-related protein receptors in humans is associated with abnormal breast development and tooth impaction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Compatible with the involvement of PTHR1 and PTHrP in human breast and tooth morphogenesis, both were expressed within the developing breasts and teeth of normal human fetuses."
    explanation: Establishes that the ligand and receptor are expressed at the affected sites in normal human fetal development.
  notes: >
    GO has no term for PTHrP-dependent epithelial-mesenchymal signaling in
    mammary or tooth development. GO:0071374 is the closest available process:
    it names the cellular response to the ligand class this receptor transduces,
    which is exactly what is lost here, but it says nothing about the
    epithelial-mesenchymal interaction or the tissues involved. The binding is
    kept because it is accurate as far as it goes; the more specific claim is
    carried by preferred_term and by this node's description rather than by a
    manufactured narrower term.
phenotypes:
- category: Skeletal
  name: Severe micromelia
  description: >
    Extreme shortening of all four limbs (tetramicromelia), the most conspicuous
    prenatal sonographic finding and the feature that first raises the
    possibility of a lethal skeletal dysplasia.
  diagnostic: true
  phenotype_term:
    preferred_term: Tetramicromelia
    term:
      id: HP:0002983
      label: Micromelia
  notes: >
    5 of 5 fetuses in the single largest published series presented with
    tetramicromelia on prenatal ultrasound. No FrequencyEnum band is asserted:
    the observed fraction is 100%, but a denominator of 5 cannot distinguish
    OBLIGATE from VERY_FREQUENT, and the series is a referred prenatal-diagnosis
    cohort rather than a complete ascertainment.
  evidence:
  - reference: PMID:35808914
    reference_title: "Prenatal ultrasonographic features in Blomstrand osteochondrodysplasia: Antenatal case series confirmed by postmortem radiology and molecular diagnosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All fetuses presented with severe sonographic findings of LSDs comprising tetramicromelia, thoracic hypoplasia, and retro-micrognathia."
    explanation: All five fetuses in the series had tetramicromelia.
  - reference: PMID:9268097
    reference_title: "Familial Blomstrand chondrodysplasia with advanced skeletal maturation: further delineation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The hallmarks of this affection, also called Blomstrand chondrodysplasia, are short limbs, polyhydramnios, hydrops fetalis, facial anomalies, increased bone density, and a remarkable advance in skeletal maturation."
    explanation: Lists short limbs among the hallmark features of the condition.
- category: Skeletal
  name: Accelerated skeletal maturation
  description: >
    Ossification is grossly advanced for gestational age — the single most
    characteristic radiological finding, and the feature the disease is named
    for in the original delineation.
  diagnostic: true
  phenotype_term:
    preferred_term: Accelerated skeletal maturation
    term:
      id: HP:0005616
      label: Accelerated skeletal maturation
  notes: >
    Advanced bone maturation was present on postmortem radiography in 4 of the 4
    fetuses so evaluated in the largest published series. No FrequencyEnum band
    is asserted: a denominator of 4 cannot distinguish OBLIGATE from
    VERY_FREQUENT.
  evidence:
  - reference: PMID:10552065
    reference_title: "Blomstrand chondrodysplasia: a lethal sclerosing skeletal dysplasia. Case report and review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The main findings in this lethal osteochondrodysplasia are osteosclerosis and advanced skeletal maturation."
    explanation: Names advanced skeletal maturation as a cardinal finding.
  - reference: PMID:10552065
    reference_title: "Blomstrand chondrodysplasia: a lethal sclerosing skeletal dysplasia. Case report and review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Histopathological study of the bones confirmed the advanced skeletal maturation radiological features."
    explanation: Histology confirms that the radiographic impression reflects true tissue-level advanced maturation.
- category: Skeletal
  name: Generalized osteosclerosis
  description: >
    Diffuse increase in bone density affecting the whole skeleton, reflecting the
    excess of prematurely formed bone.
  diagnostic: true
  phenotype_term:
    preferred_term: Generalized osteosclerosis
    term:
      id: HP:0005789
      label: Generalized osteosclerosis
  notes: >
    Generalized osteosclerosis was present on postmortem radiography in 4 of the
    4 fetuses so evaluated in the largest published series. No FrequencyEnum band
    is asserted: a denominator of 4 cannot distinguish OBLIGATE from
    VERY_FREQUENT.
  evidence:
  - reference: PMID:35808914
    reference_title: "Prenatal ultrasonographic features in Blomstrand osteochondrodysplasia: Antenatal case series confirmed by postmortem radiology and molecular diagnosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "X-rays of four fetuses evaluated postmortem showed advanced bone maturation, generalized osteosclerosis, and dumbbell-like appearance of long bones due to metaphyseal enlargement."
    explanation: Radiographic documentation of generalized osteosclerosis in molecularly confirmed cases.
- category: Skeletal
  name: Dumbbell-shaped long bones with metaphyseal flaring
  description: >
    Long bones show a dumbbell outline created by metaphyseal enlargement and
    flaring — a discriminating radiographic sign in the differential diagnosis of
    lethal skeletal dysplasia.
  diagnostic: true
  phenotype_term:
    preferred_term: Dumbbell-shaped long bones
    term:
      id: HP:0002810
      label: Dumbbell-shaped metaphyses
  evidence:
  - reference: PMID:35808914
    reference_title: "Prenatal ultrasonographic features in Blomstrand osteochondrodysplasia: Antenatal case series confirmed by postmortem radiology and molecular diagnosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "X-rays of four fetuses evaluated postmortem showed advanced bone maturation, generalized osteosclerosis, and dumbbell-like appearance of long bones due to metaphyseal enlargement."
    explanation: Direct radiographic description of the dumbbell appearance and its metaphyseal basis.
  - reference: PMID:35808914
    reference_title: "Prenatal ultrasonographic features in Blomstrand osteochondrodysplasia: Antenatal case series confirmed by postmortem radiology and molecular diagnosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The presence of retro-micrognathia along with a protruding tongue and severe metaphyseal flaring can suggest a diagnosis of BOCD, when prenatal ultrasound findings are indicative for LSD."
    explanation: Identifies severe metaphyseal flaring as part of the diagnostic triad proposed by the authors.
- category: Skeletal
  name: Thoracic hypoplasia
  description: >
    A small, narrow thorax with short ribs, which restricts fetal lung growth and
    is the proximate cause of respiratory failure in liveborn infants.
  phenotype_term:
    preferred_term: Thoracic hypoplasia
    term:
      id: HP:0005257
      label: Thoracic hypoplasia
  notes: >
    5 of 5 fetuses in the largest published series had thoracic hypoplasia on
    prenatal ultrasound. No FrequencyEnum band is asserted: a denominator of 5
    cannot distinguish OBLIGATE from VERY_FREQUENT.
  sequelae:
  - target: Perinatal lethality
    description: >
      A hypoplastic thorax cannot support postnatal ventilation, so liveborn
      infants die of respiratory insufficiency.
    evidence:
    - reference: PMID:35808914
      reference_title: "Prenatal ultrasonographic features in Blomstrand osteochondrodysplasia: Antenatal case series confirmed by postmortem radiology and molecular diagnosis."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Blomstrand osteochondrodysplasia (BOCD, MIM #215045) is an ultrarare lethal skeletal dysplasia (LSD) perinatally, characterized by extremely advanced bone maturation, generalized osteosclerosis, and severe tetramicromelia caused by biallelic loss-of-function mutations in the parathyroid hormone receptor-1 gene (PTHR1)."
      explanation: >
        Establishes that this is a perinatally lethal skeletal dysplasia. The
        specific attribution of death to thoracic hypoplasia follows from the
        general pathophysiology of lethal short-rib dysplasias rather than from a
        cause-of-death analysis in these fetuses, so this edge is indirect.
      directness: INDIRECT
  evidence:
  - reference: PMID:35808914
    reference_title: "Prenatal ultrasonographic features in Blomstrand osteochondrodysplasia: Antenatal case series confirmed by postmortem radiology and molecular diagnosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All fetuses presented with severe sonographic findings of LSDs comprising tetramicromelia, thoracic hypoplasia, and retro-micrognathia."
    explanation: All five fetuses in the series had thoracic hypoplasia.
- category: Craniofacial
  name: Retro-micrognathia
  description: >
    A receding, hypoplastic mandible, part of the characteristic facial profile.
  diagnostic: true
  phenotype_term:
    preferred_term: Retro-micrognathia
    term:
      id: HP:0000278
      label: Retrognathia
  notes: >
    5 of 5 fetuses in the largest published series had retro-micrognathia on
    prenatal ultrasound. No FrequencyEnum band is asserted: a denominator of 5
    cannot distinguish OBLIGATE from VERY_FREQUENT.
  evidence:
  - reference: PMID:35808914
    reference_title: "Prenatal ultrasonographic features in Blomstrand osteochondrodysplasia: Antenatal case series confirmed by postmortem radiology and molecular diagnosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All fetuses presented with severe sonographic findings of LSDs comprising tetramicromelia, thoracic hypoplasia, and retro-micrognathia."
    explanation: All five fetuses in the series had retro-micrognathia.
  sequelae:
  - target: Protruding tongue
    description: >
      A receding, hypoplastic mandible leaves an oral cavity too small for the
      tongue, which is displaced forward out of the mouth.
    evidence:
    - reference: PMID:35808914
      reference_title: "Prenatal ultrasonographic features in Blomstrand osteochondrodysplasia: Antenatal case series confirmed by postmortem radiology and molecular diagnosis."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The presence of retro-micrognathia along with a protruding tongue and severe metaphyseal flaring can suggest a diagnosis of BOCD, when prenatal ultrasound findings are indicative for LSD."
      explanation: >
        The source reports the two features together as part of one prenatal
        sign; the direction of the link — a small mandible crowding the tongue
        forward — is the standard craniofacial inference and is not itself
        measured in these fetuses.
      directness: INDIRECT
- category: Craniofacial
  name: Protruding tongue
  description: >
    The tongue protrudes from a small oral cavity constrained by the hypoplastic
    mandible; together with retro-micrognathia and metaphyseal flaring it forms
    the prenatal diagnostic triad proposed for this condition.
  diagnostic: true
  phenotype_term:
    preferred_term: Protruding tongue
    term:
      id: HP:0010808
      label: Protruding tongue
  evidence:
  - reference: PMID:35808914
    reference_title: "Prenatal ultrasonographic features in Blomstrand osteochondrodysplasia: Antenatal case series confirmed by postmortem radiology and molecular diagnosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The presence of retro-micrognathia along with a protruding tongue and severe metaphyseal flaring can suggest a diagnosis of BOCD, when prenatal ultrasound findings are indicative for LSD."
    explanation: Names the protruding tongue as one of the three suggestive prenatal features.
- category: Prenatal
  name: Polyhydramnios
  description: >
    Excess amniotic fluid, a common non-specific accompaniment of lethal
    skeletal dysplasia and a frequent reason for the referral ultrasound.
  phenotype_term:
    preferred_term: Polyhydramnios
    term:
      id: HP:0001561
      label: Polyhydramnios
  evidence:
  - reference: PMID:27353973
    reference_title: "Usefulness of fetal autopsy in the diagnosis of blomstrand chondrodysplasia: a report of three cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Antenatal ultrasound findings include increased nuchal translucency, tetramicromelia and polyhydramnios."
    explanation: Lists polyhydramnios among the antenatal ultrasound findings.
  - reference: PMID:9268097
    reference_title: "Familial Blomstrand chondrodysplasia with advanced skeletal maturation: further delineation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The hallmarks of this affection, also called Blomstrand chondrodysplasia, are short limbs, polyhydramnios, hydrops fetalis, facial anomalies, increased bone density, and a remarkable advance in skeletal maturation."
    explanation: Lists polyhydramnios among the hallmark features.
- category: Prenatal
  name: Increased nuchal translucency
  description: >
    Increased nuchal translucency in the first or early second trimester, which
    in reported cases prompted the detailed anomaly scan that found the skeletal
    dysplasia.
  phenotype_term:
    preferred_term: Increased nuchal translucency
    term:
      id: HP:0010880
      label: Increased nuchal translucency
  evidence:
  - reference: PMID:27353973
    reference_title: "Usefulness of fetal autopsy in the diagnosis of blomstrand chondrodysplasia: a report of three cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Antenatal ultrasound findings include increased nuchal translucency, tetramicromelia and polyhydramnios."
    explanation: Lists increased nuchal translucency among the antenatal findings.
- category: Prenatal
  name: Hydrops fetalis
  description: >
    Generalized fetal fluid accumulation, reported as a hallmark in the familial
    cases that delineated the condition.
  phenotype_term:
    preferred_term: Hydrops fetalis
    term:
      id: HP:0001789
      label: Hydrops fetalis
  evidence:
  - reference: PMID:9268097
    reference_title: "Familial Blomstrand chondrodysplasia with advanced skeletal maturation: further delineation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The hallmarks of this affection, also called Blomstrand chondrodysplasia, are short limbs, polyhydramnios, hydrops fetalis, facial anomalies, increased bone density, and a remarkable advance in skeletal maturation."
    explanation: Lists hydrops fetalis among the hallmark features.
- category: Integumentary
  name: Absent nipple
  description: >
    Absence of the nipple, the human counterpart of the failure of mammary
    development seen when PTHrP-PTH1R signaling is disrupted in mice. An
    extraskeletal feature that is easily missed unless specifically sought at
    autopsy. Curated separately from the absence of breast tissue because the
    two are distinct HPO terms; the single reported observation records both.
  phenotype_term:
    preferred_term: Absent nipple
    term:
      id: HP:0002561
      label: Absent nipple
  evidence:
  - reference: PMID:11297619
    reference_title: Absence of functional type 1 parathyroid hormone (PTH)/PTH-related protein receptors in humans is associated with abnormal breast development and tooth impaction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "These fetuses lack nipples and breasts."
    explanation: Direct autopsy observation in two Blomstrand fetuses.
- category: Integumentary
  name: Breast aplasia
  description: >
    Absence of breast tissue in the same fetuses, the mammary-gland half of the
    extraskeletal PTHrP-PTH1R developmental defect.
  phenotype_term:
    preferred_term: Breast aplasia
    term:
      id: HP:0100783
      label: Breast aplasia
  evidence:
  - reference: PMID:11297619
    reference_title: Absence of functional type 1 parathyroid hormone (PTH)/PTH-related protein receptors in humans is associated with abnormal breast development and tooth impaction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "These fetuses lack nipples and breasts."
    explanation: Direct autopsy observation in two Blomstrand fetuses.
- category: Cardiovascular
  name: Coarctation of the aorta
  description: >
    Narrowing of the aorta, reported in some Blomstrand cases. Whether PTH1R
    deficiency causes it directly is explicitly unresolved in the source that
    states the association.
  phenotype_term:
    preferred_term: Coarctation of aorta
    term:
      id: HP:0001680
      label: Coarctation of aorta
  notes: >
    No frequency band is asserted. The only cached source that states the
    association describes it as occurring "in some cases" and gives no
    numerator or denominator, and this entry has no cached primary case series
    that counts it. The phenotype is also left with no incoming causal edge: the
    same source says it is unclear whether PTH1R deficiency causes coarctation
    directly in humans, and the mechanism it proposes, Notch-dependent loss of
    aortic endothelium, was demonstrated in zebrafish morphants rather than in
    patients. Drawing the edge would assert a human causal claim the source
    declines to make.
  evidence:
  - reference: DOI:10.1161/ATVBAHA.112.300590
    reference_title: Loss of Function of Parathyroid Hormone Receptor 1 Induces Notch-Dependent Aortic Defects During Zebrafish Vascular Development
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Blomstrand chondrodysplasia, caused by mutations in the parathyroid hormone receptor 1 (PTHR1) is associated with coarctation of the aorta in some cases, although it is unclear whether PTHR1 deficiency causes coarctation of the aorta directly."
    explanation: >-
      States the human association and, in the same sentence, that its causal
      status is unresolved. Graded MODEL_ORGANISM because the cited publication
      is a zebrafish knockdown study; this sentence is its background summary of
      the human literature rather than a result of its own.
- category: Dental
  name: Impacted teeth
  description: >
    Developing teeth are present but severely impacted within the alveolar bone,
    with distorted architecture and orientation.
  phenotype_term:
    preferred_term: Impacted tooth
    term:
      id: HP:0011079
      label: Impacted tooth
  evidence:
  - reference: PMID:11297619
    reference_title: Absence of functional type 1 parathyroid hormone (PTH)/PTH-related protein receptors in humans is associated with abnormal breast development and tooth impaction.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Developing teeth were present, but they were severely impacted within the surrounding alveolar bone, leading to distortions in their architecture and orientation."
    explanation: Direct autopsy observation of tooth impaction.
- category: Constitutional
  name: Perinatal lethality
  description: >
    The condition is uniformly lethal: affected pregnancies end in stillbirth or
    the infant dies shortly after birth. No survivor has been reported.
  frequency: OBLIGATE
  phenotype_term:
    preferred_term: Perinatal lethality
  notes: >
    Deliberately left unbound. HP:0003826 (Stillbirth) is the closest label match
    but is not a member of the PhenotypeTerm dynamic enum (it sits outside the
    Phenotypic abnormality subtree), and the mortality terms HP:0003811 (Neonatal
    death) and HP:0001522 (Death in infancy) are clinical-course modifiers rather
    than phenotypic abnormalities. Reported outcomes span both stillbirth
    (PMID:10552065) and perinatal death, so no single existing HPO phenotypic
    abnormality covers the claim; a wrong binding would be worse than none.
  evidence:
  - reference: PMID:35808914
    reference_title: "Prenatal ultrasonographic features in Blomstrand osteochondrodysplasia: Antenatal case series confirmed by postmortem radiology and molecular diagnosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Blomstrand osteochondrodysplasia (BOCD, MIM #215045) is an ultrarare lethal skeletal dysplasia (LSD) perinatally, characterized by extremely advanced bone maturation, generalized osteosclerosis, and severe tetramicromelia caused by biallelic loss-of-function mutations in the parathyroid hormone receptor-1 gene (PTHR1)."
    explanation: States that the condition is perinatally lethal.
  - reference: PMID:10552065
    reference_title: "Blomstrand chondrodysplasia: a lethal sclerosing skeletal dysplasia. Case report and review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We report a female stillborn with typical clinical, radiological, and anatomopathological features of Blomstrand chondrodysplasia."
    explanation: Documents stillbirth as the outcome in a phenotypically typical case.
genetic:
- name: PTH1R
  gene_term:
    preferred_term: PTH1R
    term:
      id: hgnc:9608
      label: PTH1R
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  inheritance:
  - name: Autosomal recessive
    inheritance_term:
      preferred_term: Autosomal recessive inheritance
      term:
        id: HP:0000007
        label: Autosomal recessive inheritance
    evidence:
    - reference: PMID:27353973
      reference_title: "Usefulness of fetal autopsy in the diagnosis of blomstrand chondrodysplasia: a report of three cases."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Blomstrand osteochondrodysplasia (BOCD) is a rare autosomal recessive sclerosing skeletal dysplasia characterized by accelerated chondrocyte differentiation."
      explanation: States the recessive inheritance pattern.
  notes: >
    PTH1R at 3p21.31 encodes the 593-residue type 1 PTH/PTHrP receptor, a class B
    G protein-coupled receptor that couples to both Gs (cAMP) and Gq (inositol
    phosphate) pathways. Reported Blomstrand alleles include a homozygous P132L
    missense substitution in the N-terminal extracellular ligand-binding domain
    (recovered independently by two groups) and a maternally inherited
    splice-site-creating substitution at nucleotide 1176 that deletes the first
    11 residues of the fifth transmembrane domain, with the paternal allele not
    expressed. A later five-family series adds two more: a homozygous nonsense
    allele, R104X, which truncates the receptor and is assigned to the severe
    type I form, and a homozygous intronic substitution (designated intron
    M4+27C>T) that creates a novel splice site preferentially used in patient
    fibroblasts while a low level of wild-type transcript survives, assigned to
    the milder type II form along with P132L. The allelic spectrum here is
    limited to alleles supported by a cached source; a 2025 review surfaced by
    the deep-research artifact lists a further frameshift allele, c.1093delG,
    which is not recorded here because that review is not in references_cache.
    PTH1R
    is the locus of a striking allelic series in which the direction of the
    receptor defect predicts the direction of the skeletal phenotype: constitutively
    activating heterozygous alleles cause Jansen metaphyseal chondrodysplasia with
    delayed chondrocyte differentiation, complete loss-of-function recessive alleles
    cause Blomstrand chondrodysplasia with accelerated differentiation, and a
    recessive C-terminal cytoplasmic-tail truncation causes Eiken syndrome with
    delayed ossification.
  evidence:
  - reference: PMID:35808914
    reference_title: "Prenatal ultrasonographic features in Blomstrand osteochondrodysplasia: Antenatal case series confirmed by postmortem radiology and molecular diagnosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Blomstrand osteochondrodysplasia (BOCD, MIM #215045) is an ultrarare lethal skeletal dysplasia (LSD) perinatally, characterized by extremely advanced bone maturation, generalized osteosclerosis, and severe tetramicromelia caused by biallelic loss-of-function mutations in the parathyroid hormone receptor-1 gene (PTHR1)."
    explanation: Attributes the condition to biallelic loss-of-function PTH1R variants.
  - reference: PMID:15525660
    reference_title: Recessive mutations in PTHR1 cause contrasting skeletal dysplasias in Eiken and Blomstrand syndromes.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "To our knowledge, this is the first description of opposite manifestations resulting from distinct recessive mutations in the same gene."
    explanation: Documents that different recessive PTH1R alleles produce opposite skeletal phenotypes, the basis for the allelic-series note above.
  - reference: DOI:10.1210/jc.2006-0300
    reference_title: "Novel Mutations in the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Type 1 Causing Blomstrand Osteochondrodysplasia Types I and II"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In one of the type I BOCD cases, a homozygous nonsense mutation (R104X) was found, resulting in a truncated PTHR1."
    explanation: The R104X allele added to the allelic spectrum above.
  - reference: DOI:10.1210/jc.2006-0300
    reference_title: "Novel Mutations in the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Type 1 Causing Blomstrand Osteochondrodysplasia Types I and II"
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "In dermal fibroblasts of the patient, this novel splice site was preferentially used, resulting in an aberrant transcript. The wild-type transcript remained, however, present, albeit at low levels."
    explanation: The intronic splice-creating allele and the residual wild-type transcript that defines it as hypomorphic.
diagnosis:
- name: Prenatal ultrasound
  description: >
    Second-trimester ultrasound showing severe shortening of all four limbs with
    a hypoplastic thorax and retro-micrognathia establishes that a lethal
    skeletal dysplasia is present; a protruding tongue and severe metaphyseal
    flaring narrow that to Blomstrand osteochondrodysplasia.
  evidence:
  - reference: PMID:35808914
    reference_title: "Prenatal ultrasonographic features in Blomstrand osteochondrodysplasia: Antenatal case series confirmed by postmortem radiology and molecular diagnosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The presence of retro-micrognathia along with a protruding tongue and severe metaphyseal flaring can suggest a diagnosis of BOCD, when prenatal ultrasound findings are indicative for LSD."
    explanation: States the prenatal sonographic features that suggest this specific diagnosis.
- name: Postmortem radiography and fetal autopsy
  description: >
    Babygram after delivery or termination shows advanced bone maturation,
    generalized osteosclerosis and dumbbell-shaped long bones; histology of the
    long bones shows the narrow cartilaginous cap and disorganized physis that
    confirm the diagnosis when molecular testing is unavailable.
  evidence:
  - reference: PMID:27353973
    reference_title: "Usefulness of fetal autopsy in the diagnosis of blomstrand chondrodysplasia: a report of three cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In this article, we discuss three cases where lethal skeletal dysplasia was suspected and Blomstrand dysplasia was diagnosed by autopsy."
    explanation: Establishes fetal autopsy as the diagnostic modality in three reported cases.
- name: PTH1R sequencing
  description: >
    Identification of biallelic loss-of-function PTH1R variants confirms the
    diagnosis and is what makes accurate recurrence-risk counselling and
    subsequent prenatal testing possible.
  evidence:
  - reference: PMID:35808914
    reference_title: "Prenatal ultrasonographic features in Blomstrand osteochondrodysplasia: Antenatal case series confirmed by postmortem radiology and molecular diagnosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The diagnosis can be ascertained through postmortem clinical and radiological evaluation and/or molecular testing."
    explanation: States that molecular testing is a route to diagnostic confirmation.
differential_diagnoses:
- name: Jansen metaphyseal chondrodysplasia
  description: >
    The other end of the PTH1R allelic series. Jansen is caused by heterozygous
    constitutively activating PTH1R variants and shows delayed, not accelerated,
    chondrocyte differentiation and endochondral ossification; it is compatible
    with survival to adulthood. The two conditions are radiographic mirror
    images and are distinguished by the direction of the skeletal maturation
    abnormality as well as by inheritance pattern.
  evidence:
  - reference: PMID:9649554
    reference_title: Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "abnormalities that are the mirror image of those observed in Jansen's chondrodysplasia"
    explanation: States the mirror-image relationship between the two PTH1R disorders.
- name: Eiken syndrome
  description: >
    Also recessive and also PTH1R-related, but caused by truncation of the
    C-terminal cytoplasmic tail rather than by complete loss of ligand binding.
    Eiken syndrome is survivable and shows delayed ossification, the opposite
    skeletal direction to Blomstrand.
  evidence:
  - reference: PMID:15525660
    reference_title: Recessive mutations in PTHR1 cause contrasting skeletal dysplasias in Eiken and Blomstrand syndromes.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We identified a truncation mutation in the C-terminal cytoplasmic tail of the parathyroid hormone (PTH)/PTH-related peptide (PTHrP) type 1 receptor (PTHR1) gene as the cause of this syndrome."
    explanation: Identifies the distinct Eiken allele class within the same gene.
- name: Other lethal short-rib skeletal dysplasias
  description: >
    Thanatophoric dysplasia, short-rib polydactyly syndromes and osteogenesis
    imperfecta type II all present prenatally with severe micromelia and a
    hypoplastic thorax. What separates Blomstrand from all of them is the
    direction of skeletal maturation: advanced ossification with generalized
    osteosclerosis rather than deficient or disordered mineralization.
  evidence:
  - reference: PMID:35808914
    reference_title: "Prenatal ultrasonographic features in Blomstrand osteochondrodysplasia: Antenatal case series confirmed by postmortem radiology and molecular diagnosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We aim to describe prenatal ultrasonographic features in a retrospective fetal case series of BOCD and emphasize the importance of multidisciplinary antenatal evaluation of LSDs to improve the differential diagnosis."
    explanation: Frames the case series explicitly as a contribution to the differential diagnosis of lethal skeletal dysplasias.
treatments:
- name: Genetic counselling and recurrence-risk assessment
  description: >
    There is no treatment for the fetus. The clinically actionable intervention
    is counselling the couple: a 25% recurrence risk per pregnancy, carrier
    testing where the causal PTH1R alleles are known, and the option of targeted
    molecular prenatal diagnosis or early anomaly scanning in a subsequent
    pregnancy. Recurrence in sibs is documented, so this is not a theoretical
    concern.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:9268097
    reference_title: "Familial Blomstrand chondrodysplasia with advanced skeletal maturation: further delineation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We report on two sibs with a rare lethal chondrodysplasia born to a non-consanguineous couple."
    explanation: Documents sib recurrence in a non-consanguineous couple, which is what makes recurrence-risk counselling necessary.
- name: Perinatal comfort and supportive care
  description: >
    For a liveborn infant, management is comfort-directed: the thorax cannot
    support ventilation and no intervention alters the outcome. Care is aimed at
    symptom relief and family support rather than at the disease.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Supportive Care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:35808914
    reference_title: "Prenatal ultrasonographic features in Blomstrand osteochondrodysplasia: Antenatal case series confirmed by postmortem radiology and molecular diagnosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Blomstrand osteochondrodysplasia (BOCD, MIM #215045) is an ultrarare lethal skeletal dysplasia (LSD) perinatally, characterized by extremely advanced bone maturation, generalized osteosclerosis, and severe tetramicromelia caused by biallelic loss-of-function mutations in the parathyroid hormone receptor-1 gene (PTHR1)."
    explanation: >
      The perinatally lethal course is what makes comfort-directed rather than
      disease-modifying care appropriate; no trial or guideline for supportive
      management of this specific condition exists, so this is an inference from
      the natural history.
    directness: INDIRECT
animal_models:
- name: PTH/PTHrP receptor null mouse
  species: Mus musculus
  genotype: Pth1r (PTH/PTHrP receptor) homozygous null, generated by homologous recombination
  category: KNOCKOUT
  genes:
  - preferred_term: PTH1R
    term:
      id: hgnc:9608
      label: PTH1R
  publication: PMID:8662561
  description: >
    Germline deletion of the murine PTH/PTHrP receptor. Most homozygotes die in
    mid-gestation; survivors show accelerated chondrocyte differentiation, and
    their bones are refractory to PTHrP and hedgehog in explant culture. This is
    the closest available model of the human disease and it reproduces both the
    cellular lesion and the lethality.
  modeled_mechanisms:
  - target: Accelerated Chondrocyte Hypertrophic Differentiation
    relationship: RECAPITULATES
    fidelity: HIGH
    description: >
      Receptor-null mice show the same accelerated chondrocyte differentiation
      that defines the human condition, from the same molecular lesion (complete
      loss of PTH1R function).
    limitations: >-
      The mouse is a complete germline null while human Blomstrand alleles are
      point mutations that leave a surface-expressed but signaling-dead receptor,
      and most null embryos die in mid-gestation before the skeletal phenotype
      can be fully assessed, so the surviving embryos are a selected subset.
      Radiographic osteosclerosis, the cardinal human finding, is not reported in
      this paper.
    readouts:
    - name: Chondrocyte differentiation timing in developing bone
      target: Accelerated Chondrocyte Hypertrophic Differentiation
      direction: INCREASED
      interpretation: >
        Accelerated differentiation in the receptor-null mouse is the direct
        cellular counterpart of the accelerated chondrocyte differentiation
        described in human Blomstrand autopsy histology.
      evidence:
      - reference: PMID:8662561
        reference_title: PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "Mice that survived exhibited accelerated differentiation of chondrocytes in bone, and their bones, grown in explant culture, were resistant to the effects of PTHrP and Sonic hedgehog."
        explanation: Reports the accelerated differentiation phenotype and the associated ligand resistance.
    evidence:
    - reference: PMID:10912527
      reference_title: Role of parathyroid hormone-related peptide and Indian hedgehog in skeletal development.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Mice lacking PTHrP show accelerated chondrocyte differentiation, and thus premature ossification of those bones that are formed through an endochondral process, and similar but more-severe abnormalities are observed in PTH1R-ablated animals."
      explanation: Independent review confirming that PTH1R ablation in mice reproduces (more severely) the accelerated-differentiation phenotype.
  - target: Failure of PTH/PTHrP-Stimulated Signaling in Growth Plate Chondrocytes
    relationship: RECAPITULATES
    fidelity: HIGH
    description: >
      Explanted receptor-null bone is unresponsive to PTHrP and hedgehog,
      demonstrating in tissue the same signaling failure shown for human
      Blomstrand alleles in transfected cells.
    limitations: >-
      Responsiveness was assayed in explant culture rather than in vivo, and the
      hedgehog ligand used was Sonic rather than Indian hedgehog.
    readouts:
    - name: Responsiveness of explanted bone to PTHrP and hedgehog
      target: Failure of PTH/PTHrP-Stimulated Signaling in Growth Plate Chondrocytes
      direction: ABOLISHED
      interpretation: >
        Loss of ligand responsiveness in receptor-null tissue is the tissue-level
        equivalent of the abolished cAMP and inositol phosphate response measured
        for Blomstrand alleles in transfected cells.
      evidence:
      - reference: PMID:8662561
        reference_title: PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "Mice that survived exhibited accelerated differentiation of chondrocytes in bone, and their bones, grown in explant culture, were resistant to the effects of PTHrP and Sonic hedgehog."
        explanation: Documents the loss of ligand responsiveness in receptor-null bone.
    evidence:
    - reference: PMID:8662561
      reference_title: PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "These results suggest that the PTH/PTHrP receptor mediates the effects of Indian Hedgehog and PTHrP on chondrocyte differentiation."
      explanation: Supports treating the receptor-null mouse as informative for the human signaling-failure node.
  evidence:
  - reference: PMID:8662561
    reference_title: PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Most PTH/PTHrP receptor (-/-) mutant mice died in mid-gestation, a phenotype not observed in PTHrP (-/-) mice, perhaps because of the effects of maternal PTHrP."
    explanation: Establishes that receptor ablation, unlike ligand ablation, is embryonic-lethal in the mouse, paralleling the perinatal lethality of the human condition.
discussions:
- discussion_id: blomstrand_osteosclerosis_absent_from_mouse_null
  kind: HUMAN_MODEL_MISMATCH
  prompt: >
    Why is generalized osteosclerosis a cardinal radiographic feature of human
    Blomstrand chondrodysplasia when the PTH/PTHrP receptor-null mouse is
    reported for accelerated chondrocyte differentiation and mid-gestation
    lethality rather than for increased bone density?
  rationale: >
    The cellular lesion — accelerated chondrocyte differentiation — is faithfully
    reproduced in the Pth1r-null mouse, and the review literature states that
    PTH1R-ablated animals show premature endochondral ossification. But the
    defining human radiographic finding, generalized osteosclerosis, is not what
    the mouse work reports; most null embryos die in mid-gestation, before a
    skeleton dense enough to assess radiographically has formed. It is therefore
    unresolved whether human osteosclerosis is simply the accumulated end state
    of premature ossification carried to 25-40 weeks of gestation, or whether it
    additionally requires a species-specific or later-gestation contribution
    (for example altered osteoclast activity in the absence of PTH1R signaling in
    bone) that the mouse never lives long enough to display. This matters because
    it determines whether the mouse can be used to test any intervention aimed at
    the sclerotic phenotype.
  attaches_to:
  - pathophysiology#Premature and Advanced Endochondral Ossification
  - phenotypes#Generalized osteosclerosis
  proposed_experiments:
  - experiment_id: blomstrand_conditional_pth1r_late_gestation
    name: Chondrocyte-restricted, late-gestation Pth1r deletion with skeletal radiography
    description: >
      Delete Pth1r conditionally in growth plate chondrocytes at a stage that
      bypasses mid-gestation lethality, and image the skeleton radiographically
      and by micro-CT through late gestation and the perinatal period, to test
      whether generalized osteosclerosis emerges once the animal survives long
      enough.
    would_support:
    - phenotypes#Generalized osteosclerosis
    supporting_outcome:
    - Radiographic bone density rises progressively once mid-gestation lethality is bypassed, reproducing the human sclerotic phenotype from the same chondrocyte-autonomous lesion
    refuting_outcome:
    - Late-gestation chondrocyte-restricted deletion accelerates ossification without producing generalized osteosclerosis, implying an additional non-chondrocyte or human-specific contribution
  - experiment_id: blomstrand_bse_histomorphometry
    name: Quantitative mineral density distribution in human Blomstrand bone
    description: >
      Quantitative backscattered-electron imaging and histomorphometry on
      non-decalcified bone from molecularly confirmed Blomstrand fetuses,
      compared with gestational-age-matched controls, to establish whether the
      radiographic osteosclerosis reflects true tissue hypermineralization or the
      geometry of prematurely ossified, structurally abnormal bone.
    would_support:
    - pathophysiology#Premature and Advanced Endochondral Ossification
    supporting_outcome:
    - Tissue mineral density is normal and the radiographic density reflects prematurely formed bone occupying space that should still be cartilage
    refuting_outcome:
    - Bone tissue is genuinely hypermineralized, implying a mineralization defect additional to accelerated ossification
  evidence:
  - reference: PMID:8662561
    reference_title: PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Most PTH/PTHrP receptor (-/-) mutant mice died in mid-gestation, a phenotype not observed in PTHrP (-/-) mice, perhaps because of the effects of maternal PTHrP."
    explanation: The mid-gestation lethality that truncates the mouse skeletal phenotype is the basis of the mismatch.
  - reference: PMID:35808914
    reference_title: "Prenatal ultrasonographic features in Blomstrand osteochondrodysplasia: Antenatal case series confirmed by postmortem radiology and molecular diagnosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "X-rays of four fetuses evaluated postmortem showed advanced bone maturation, generalized osteosclerosis, and dumbbell-like appearance of long bones due to metaphyseal enlargement."
    explanation: Documents the human radiographic osteosclerosis that the mouse literature does not report.
notes: >
  Nomenclature: the condition is reported under several names — Blomstrand
  chondrodysplasia, Blomstrand lethal osteochondrodysplasia, and Blomstrand
  osteochondrodysplasia (BOCD) — and the causal gene is written both PTH1R (HGNC
  approved symbol, used here) and PTHR1 (used in much of the primary literature,
  including in quoted snippets).

  Extraskeletal features are almost certainly under-reported. Absent nipples and
  breasts and impacted teeth were found only when specifically looked for
  (PMID:11297619), in fetuses whose earlier reports had not mentioned them. Any
  future autopsy of a suspected case should examine the breast and dentition.

  No population prevalence, natural-history cohort, or GeneReviews chapter exists
  for this condition; the evidence base is a handful of case reports and one
  five-fetus series. Numeric frequency bands here are stated only where the
  denominator is that series (5 fetuses on ultrasound, 4 on postmortem
  radiography), and even there no FrequencyEnum band is asserted, because
  denominators of 4 and 5 cannot separate OBLIGATE from VERY_FREQUENT. The
  numerator/denominator is recorded in each phenotype's notes instead. The one
  band that is asserted is OBLIGATE on perinatal lethality, which rests on the
  whole literature rather than on that series: no survivor has ever been
  reported, and lethality is definitional for this entity.
references:
- reference: PMID:9649554
  title: Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia.
- reference: PMID:35808914
  title: "Prenatal ultrasonographic features in Blomstrand osteochondrodysplasia: Antenatal case series confirmed by postmortem radiology and molecular diagnosis."
- reference: PMID:11297619
  title: Absence of functional type 1 parathyroid hormone (PTH)/PTH-related protein receptors in humans is associated with abnormal breast development and tooth impaction.
📚

References & Deep Research

References

3
PMID:9649554
Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia.
No top-level findings curated for this source.
PMID:35808914
Prenatal ultrasonographic features in Blomstrand osteochondrodysplasia: Antenatal case series confirmed by postmortem radiology and molecular diagnosis.
No top-level findings curated for this source.
PMID:11297619
Absence of functional type 1 parathyroid hormone (PTH)/PTH-related protein receptors in humans is associated with abnormal breast development and tooth impaction.
No top-level findings curated for this source.

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (1)

Review round 1: pathograph wiring, section filing, deep research · 2026-09-04T06:36:27Z · View source

Addressed the CHANGES_REQUESTED review on PR #10894. (1) Connected the extraskeletal branch: added a downstream edge from 'Biallelic PTH1R Loss-of-Function' to 'Impaired PTHrP-Dependent Epithelial-Mesenchymal Signaling in Breast and Tooth', cited to PMID:11297619's concluding sentence. (2) Gave 'Thoracic hypoplasia' an incoming edge from 'Growth Plate Hypoplasia and Disorganization', graded INDIRECT with an explanation stating that no reported study measures rib length or rib physeal histology in these fetuses and the attribution rests on ribs being endochondral bones plus co-occurrence in all five fetuses of the largest series. (3) Added a sequelae edge from 'Retro-micrognathia' to 'Protruding tongue', also INDIRECT, to carry the causal claim the tongue phenotype's description already made. (4) Removed the treatments entry 'Molecular confirmation by PTH1R testing', which duplicated the diagnosis entry 'PTH1R sequencing' (same PMID, same snippet). (5) Added research/Chondrodysplasia_Blomstrand_Type-deep-research-falcon.md, generated with 'just research-disorder falcon'; 9/9 references verified, 0 confabulation. A manual PubMed sweep of all 30 Blomstrand-indexed records plus Europe PMC full-text phrase searches found no source attributing thoracic hypoplasia to a specific upstream mechanism, which is why that edge is INDIRECT rather than DIRECT. Pathograph went from 25 nodes / 15 edges / 11 components to 24 / 18 / 7. Validation: just validate (69/69 snippets), validate-terms, check-entity-refs, check-duplicate-keys, check-causal-targets, check-enum-values, check-qualifier-terms all pass.

Falcon ▸
Chondrodysplasia Blomstrand Type: Disease-Characteristics Report
Edison Scientific Literature 30 citations 2026-09-03T23:33:22.703319

Chondrodysplasia Blomstrand Type: Disease-Characteristics Report

Executive summary

Chondrodysplasia Blomstrand type—more commonly Blomstrand osteochondrodysplasia (BOCD) or Blomstrand lethal chondrodysplasia (BLC)—is an exceptionally rare, autosomal-recessive, prenatal-onset skeletal dysplasia caused by biallelic severe loss-of-function variants in PTH1R, encoding parathyroid hormone/parathyroid hormone-related peptide receptor type 1. Loss of fetal PTHrP–PTH1R signaling prematurely drives growth-plate chondrocytes from proliferation into hypertrophy and mineralization. The resulting generalized advanced ossification, shortened bones, narrow thorax, and pulmonary hypoplasia usually cause stillbirth or death minutes to hours after delivery. There is no disease-modifying treatment or validated population prevalence estimate. The strongest evidence comes from a small number of fetal case reports/series, receptor-functional studies, knockout mice, and zebrafish experiments; quantitative phenotype frequencies should therefore be interpreted cautiously. (portalescastillo2025humandiseasescaused pages 1-2, hoogendam2007novelmutationsin pages 1-2)

1. Disease information

Definition and nomenclature

BOCD is a lethal sclerosing skeletal dysplasia characterized by accelerated endochondral ossification and advanced skeletal maturation, rather than delayed mineralization. The literature uses Blomstrand osteochondrodysplasia, Blomstrand chondrodysplasia, Blomstrand lethal osteochondrodysplasia, Blomstrand lethal chondrodysplasia, and occasionally Blomstrand syndrome. Historical publications distinguish type I, with complete PTH1R inactivation and extremely short malformed bones, from the somewhat less severe but still lethal type II, associated with small amounts of residual receptor activity. (portalescastillo2025humandiseasescaused pages 8-8, portalescastillo2025humandiseasescaused pages 2-4, hoogendam2007novelmutationsin pages 1-2)

Suggested identifiers—verify against the current release before database ingestion:

  • OMIM: 215045, Blomstrand chondrodysplasia.
  • Orphanet: commonly indexed as Blomstrand lethal chondrodysplasia; the current ORPHA numerical record should be release-validated.
  • MONDO: map through the current MONDO cross-reference to OMIM:215045; a stable MONDO number was not present in the retrieved primary literature and should not be inferred from text-mining alone.
  • MeSH: no clearly disease-specific MeSH descriptor was found; indexing generally falls under osteochondrodysplasias/chondrodysplasia.
  • ICD-10: no dedicated code; typically falls under Q77.8, other osteochondrodysplasia with defects of growth of tubular bones and spine.
  • ICD-11: use the current rare skeletal-dysplasia hierarchy; no disease-specific leaf code was verified in the retrieved evidence.

The evidence is predominantly aggregated disease-level literature derived from individually described fetuses, postmortem examinations, family segregation, and experimental models—not EHR-derived population data. Hoogendam et al. studied two type-I and three type-II families using clinical examination, imaging, histology, sequencing, RNA analysis, and receptor assays. (hoogendam2007novelmutationsin pages 1-2)

Landmark source: Hoogendam et al., published online 12 December 2006 and in March 2007, DOI: https://doi.org/10.1210/jc.2006-0300. The abstract concludes: “type I BOCD is caused by a complete inactivation of the PTHR1, whereas low levels of residual activity … result in the relatively milder presentation of type II BOCD.” (hoogendam2007novelmutationsin pages 1-2)

2. Etiology

Causal factor

The primary cause is germline biallelic PTH1R loss of function. PTH1R is a class-B G-protein-coupled receptor activated by PTH and PTHrP. In fetal growth plates, its critical ligand is PTHrP. Severe receptor loss disrupts PTHrP-dependent maintenance of proliferating chondrocytes, causing premature hypertrophic differentiation and ossification. (martin2016parathyroidhormonerelatedprotein pages 19-20, portalescastillo2025humandiseasescaused pages 1-2, portalescastillo2025humandiseasescaused pages 2-4)

Risk factors

  • Genetic: two pathogenic PTH1R alleles are required for classic BOCD. Reported lesions include nonsense, frameshift, missense, and splice-altering variants. Consanguinity increases the probability that both parents carry the same rare allele, but affected offspring have also occurred in nonconsanguineous families. (hoogendam2007novelmutationsin pages 1-2)
  • Family history: affected siblings and recurrent fetal losses are important clues. One Asian first-cousin couple had three similarly affected fetuses. (hoogendam2007novelmutationsin pages 1-2, hoogendam2007novelmutationsin pages 2-3)
  • Sex: both male and female fetuses are reported; no sex-linked difference is established.
  • Environmental, infectious, lifestyle, occupational, maternal-age, or toxicant risks: none established.

Protective factors and gene–environment interaction

No protective PTH1R allele, diet, medication, lifestyle factor, or reproducible gene–environment interaction has been reported. Because BOCD is a highly penetrant developmental receptor-null phenotype, environmental modification is not expected to prevent the skeletal lesion once an affected fetal genotype is present. This is an inference, not evidence from intervention studies.

3. Phenotypes

All manifestations are congenital/prenatal, generally severe, and nonremitting. Frequencies below are qualitative unless a study supplied a number; the literature is too small and ascertainment-biased for robust percentages.

Phenotype Character and course Suggested HPO term
Advanced skeletal maturation/generalized premature ossification Defining radiographic sign; severe and prenatal Accelerated skeletal maturation HP:0005616; abnormality of ossification HP:0000135
Generalized osteosclerosis/increased bone density Common radiographic manifestation Osteosclerosis HP:0002796; increased bone mineral density HP:0004340
Micromelia/short limbs and short tubular bones Severe, symmetric, prenatal Micromelia HP:0002983; short long bones HP:0003026
Metaphyseal broadening Tubular bones short with widened metaphyses Metaphyseal widening HP:0003016
Narrow/small thorax and short ribs Severe; directly compromises lung development Narrow chest HP:0000774; short ribs HP:0000773
Pulmonary hypoplasia/respiratory failure Major lethal complication Pulmonary hypoplasia HP:0002089; neonatal respiratory distress HP:0002643
Micrognathia, small viscerocranium, protruding tongue, flat/hypoplastic nasal bridge Characteristic craniofacial pattern Micrognathia HP:0000347; tongue protrusion HP:0010808; depressed nasal bridge HP:0005280
Macrocephaly or relatively large head Prenatal ultrasound/clinical sign in some cases Macrocephaly HP:0000256
Polyhydramnios Prenatal complication in reported pregnancies Polyhydramnios HP:0001561
Fetal hydrops/generalized edema Reported in several fetuses Hydrops fetalis HP:0001789; generalized edema HP:0000969
Premature ossification of patella, carpal/tarsal and laryngeal cartilage Highly distinctive evidence of accelerated maturation Premature ossification HP:0005616; abnormal laryngeal cartilage morphology, closest HPO mapping
Reduced resting/proliferative growth-plate zones Histopathologic abnormality Abnormal epiphyseal morphology HP:0005930; abnormal chondrocyte morphology, ontology mapping recommended
Absent nipples/mammary glands Extraskeletal developmental manifestation Athelia HP:0002550; mammary-gland aplasia HP:0010615
Tooth-development/eruption abnormality Demonstrated through the shared PTH1R pathway; often not clinically observable because of lethality Failure of tooth eruption HP:0006291
Aortic coarctation Variable; one review of historical reports and a zebrafish study cited approximately 50% of described infants, but this estimate is based on very few selected cases Coarctation of the aorta HP:0001680
Cataract/possible hypocalcemia Cataracts reported in at least two fetuses; hypocalcemia was suggested, not consistently measured Congenital cataract HP:0000519; hypocalcemia HP:0002901

A well-characterized 32-week fetus had polyhydramnios, a relatively large head, small thorax, lung hypoplasia, and very short dense tubular bones. Examination showed severe micrognathia, protruding tongue, narrow thorax, absent nipples, and symmetric limb shortening; imaging showed generalized osteosclerosis, advanced skeletal maturation, short ribs, ossified laryngeal cartilage and patella, metaphyseal broadening, and extensive carpal/tarsal ossification. (hoogendam2007novelmutationsin pages 2-3)

Histology demonstrated reduced epiphyses and resting/proliferative zones, near absence of columnar proliferating chondrocytes, disordered hypertrophic columns, and an irregular growth-plate–primary-spongiosa boundary. A 2023 reanalysis further identified ectopic calcified islands, disordered trabeculae, and AGGRECAN-positive ectopic chondrocytes in diaphyseal trabecular-like structures. (csukasi2023skeletaldiseasescaused pages 2-5, hoogendam2007novelmutationsin pages 2-3)

Quality of life: validated EQ-5D, SF-36, PROMIS, or disease-specific quality-of-life data do not exist. The disorder is usually incompatible with postnatal survival; family burden centers on fetal loss, reproductive decision-making, and perinatal bereavement.

4. Genetic and molecular information

  • Gene: PTH1R, parathyroid hormone 1 receptor; chromosome 3p21 region; HGNC-approved symbol PTH1R.
  • Protein: PTH/PTHrP receptor type 1, a seven-transmembrane class-B GPCR.
  • Origin: constitutional/germline, not somatic.
  • Inheritance: autosomal recessive.
  • Functional class: severe or complete loss of receptor signaling. Type-II disease can retain a small amount of correctly spliced transcript or residual receptor function. (portalescastillo2025humandiseasescaused pages 2-4, hoogendam2007novelmutationsin pages 1-2, hoogendam2007novelmutationsin pages 3-5)

The established severe alleles and functional interpretation are summarized below.

Nucleotide change Protein consequence Variant class Zygosity Review-reported rsID / allele-frequency field Functional effect Phenotype and nomenclature notes
c.1049+27C&gt;T p.G350fsX351 Intronic aberrant splice-donor creation; frameshift and truncation Homozygous rs2107055197; none reported Preferential aberrant splicing produces a truncated receptor lacking transmembrane domains 5–7 and the cytoplasmic C-terminus; low-level normal transcript remains; severe loss of function Type II BOCD, consistent with residual transcript. The 2007 legacy designation was “intron M4 +27C>T”; the 2025 review maps it as c.1049+27C&gt;T, p.G350fsX351 (hoogendam2007novelmutationsin pages 7-8, portalescastillo2025humandiseasescaused pages 2-4, hoogendam2007novelmutationsin pages 3-5)
c.1148G&gt;A p.L373_R383del Splice-acceptor alteration causing an in-frame deletion Compound heterozygous rs398122843; 0.7 Severe receptor loss of function Severe Blomstrand chondrodysplasia; the nucleotide change has also been reported in PTH1R-related primary failure of tooth eruption, indicating genotype–phenotype overlap (risom2013identificationofsix pages 7-7, portalescastillo2025humandiseasescaused pages 2-4)
c.310C&gt;T p.R104X Nonsense; premature termination Homozygous rs121434604; 0.14 Produces only the signal peptide and first 79 amino acids, eliminating functional extracellular, transmembrane, and intracellular domains; complete or severe loss of function Classical severe type I BOCD. The 2007 legacy description gives 338C&gt;T with R104X; the 2025 review uses c.310C&gt;T, p.R104X (hoogendam2007novelmutationsin pages 1-2, portalescastillo2025humandiseasescaused pages 2-4, hoogendam2007novelmutationsin pages 3-5)
c.395C&gt;T p.P132L Missense Homozygous rs121434599; 0.36 Markedly impaired PTHrP binding and signaling with low residual activity; classified as severe loss of function Recurrently associated with relatively milder type II BOCD, supporting a residual-activity–severity relationship (hoogendam2007novelmutationsin pages 7-8, martin2016parathyroidhormonerelatedprotein pages 19-20, hoogendam2007novelmutationsin pages 1-2, portalescastillo2025humandiseasescaused pages 2-4)
c.1093delG p.V365CfsX141 Single-nucleotide deletion; frameshift and premature termination Homozygous rs1304201852; 0.44 Severe receptor loss of function Severe lethal Blomstrand chondrodysplasia; type assignment was not specified in the extracted review table (portalescastillo2025humandiseasescaused pages 2-4, portalescastillo2025humandiseasescaused pages 8-8)
Interpretation note — — — Values above are transcribed from the 2025 review’s field labeled “allele frequency” These values are review-reported and are not necessarily validated population allele frequencies or percentages Verify against the underlying population database and version before reuse (portalescastillo2025humandiseasescaused pages 2-4)

Table: Knowledge-base summary of five established severe PTH1R loss-of-function alleles associated with lethal Blomstrand chondrodysplasia. It records functional and phenotype evidence while flagging legacy nomenclature and uncertain review-reported frequency values.

The numeric values reproduced in the artifact from the 2025 review’s “allele frequency” field are not credible as unqualified population frequencies for a lethal recessive disorder and may reflect database formatting or very-low-frequency units. They must be checked directly in the current gnomAD/ClinVar records before knowledge-base import. Absence or extreme rarity in population databases is expected for pathogenic BOCD alleles.

The 2007 functional work showed that p.R104X eliminates essentially all receptor domains. The intronic allele created a preferred aberrant splice boundary and a truncated receptor lacking transmembrane helices 5–7 and the cytoplasmic tail, although a small amount of normal transcript remained. Patient fibroblasts failed to accumulate cAMP after high-dose PTH or PTHrP. (hoogendam2007novelmutationsin pages 3-5)

No validated modifier gene, disease-specific methylation signature, histone-mark abnormality, recurrent chromosomal rearrangement, or pathogenic copy-number syndrome has been established. DEPTOR, DVL2, TAZ, HDAC4/5, MEF2, RUNX2, SOX9, and IHH are mechanistic pathway components, not proven human BOCD modifier genes.

5. Environmental information

No toxin, radiation, pollution, occupation, smoking, alcohol, nutrition, exercise pattern, medication, infection, or microbiome exposure is known to cause or trigger BOCD. It is not contagious and has no zoonotic transmission. Environmental-factor and prophylactic-vaccine fields are therefore not applicable.

6. Mechanism and pathophysiology

Ordered causal chain

  1. Biallelic severe PTH1R variants lead to absent or markedly reduced functional receptor at fetal growth-plate cells. (portalescastillo2025humandiseasescaused pages 2-4, hoogendam2007novelmutationsin pages 3-5)
  2. Loss of receptor function leads to failure of PTHrP-stimulated Gαs–adenylyl-cyclase–cAMP–PKA signaling; some variants also abolish phosphoinositide signaling. (guasto2021signalingpathwaysin pages 7-8, lai2008generegulationin pages 19-24)
  3. Reduced PTHrP signaling leads to failure to maintain resting/proliferating chondrocytes and failure to delay hypertrophic differentiation. (martin2016parathyroidhormonerelatedprotein pages 19-20, portalescastillo2025humandiseasescaused pages 1-2)
  4. Loss of this restraint leads to reduced SOX9-associated proliferative/chondrogenic activity and release of HDAC4/5–MEF2–RUNX2-mediated hypertrophic programs; the full downstream chain is demonstrated mainly in mouse growth plates and is mechanistically inferred for BOCD. (guasto2021signalingpathwaysin pages 7-8, nishimori2019pthrptargetshdac4 pages 17-17)
  5. Premature chondrocyte hypertrophy leads to early cartilage mineralization, growth-plate exhaustion/disorganization, and accelerated endochondral bone formation throughout the skeleton. (portalescastillo2025humandiseasescaused pages 1-2, hoogendam2007novelmutationsin pages 2-3)
  6. Growth-plate disruption leads to short malformed tubular bones, micromelia, osteosclerosis, advanced epiphyseal/carpal/tarsal/patellar ossification, and loss of normal bone–cartilage boundaries. (hoogendam2007novelmutationsin pages 2-3, csukasi2023skeletaldiseasescaused pages 2-5)
  7. Accelerated rib-cage ossification and short ribs lead to a small rigid thorax, pulmonary hypoplasia, inability to ventilate, and perinatal death. (portalescastillo2025humandiseasescaused pages 1-2, hoogendam2007novelmutationsin pages 2-3)
  8. Parallel branch: loss of PTHrP–PTH1R signaling during vascular development may lead to reduced local Notch signaling and endothelial loss, resulting in aortic obstruction/coarctation; this is supported by zebrafish knockdown and remains incompletely demonstrated in humans. (gray2013lossoffunction pages 5-6, gray2013lossoffunction pages 1-2)
  9. Exploratory branch: PTH1R loss may dysregulate DEPTOR–DVL2–TAZ/mTOR-linked skeletal-progenitor fate, leading to ectopic chondrocytes and disordered osteogenic/chondrogenic differentiation; direct BOCD patient-cell validation is lacking. (csukasi2023skeletaldiseasescaused pages 6-8, csukasi2023skeletaldiseasescaused pages 8-9, csukasi2023skeletaldiseasescaused pages 2-5)

Pathways and cells

The normal IHH–PTHrP feedback loop spaces hypertrophic differentiation: prehypertrophic chondrocytes produce IHH, which promotes periarticular PTHrP; PTHrP then acts on PTH1R-positive proliferating/prehypertrophic chondrocytes to delay hypertrophy. Cells moving away from the PTHrP source differentiate and re-express IHH. (martin2016parathyroidhormonerelatedprotein pages 19-20, guasto2021signalingpathwaysin pages 18-19)

PTH1R can couple to Gαs/cAMP/PKA, Gαq/PLCβ/DAG/IP3/Ca²⁺, and β-arrestin pathways. Gαs signaling supports proliferation and SOX9 while suppressing hypertrophic MEF2/RUNX2 activity via nuclear HDAC4. By contrast, PLC/Ca²⁺ signaling can favor hypertrophic differentiation. BOCD-causing receptor-null variants remove the coordinated response rather than selectively increasing one branch. (guasto2021signalingpathwaysin pages 7-8, portalescastillo2025humandiseasescaused pages 1-2)

The 2023 study found absent/low DEPTOR in BOCD ectopic chondrocytes and proposed that DEPTOR interactions with PTH1R, DVL2, and TAZ regulate TAZ localization and osteogenic/adipogenic/chondrogenic fate. However, most molecular experiments used immortalized mesenchymal cells, DEPTOR knockdown, HEK293T cells, or Jansen cells; BOCD patient cells were unavailable. These results are promising pathway refinement, not a validated therapeutic target. (csukasi2023skeletaldiseasescaused pages 6-8, csukasi2023skeletaldiseasescaused pages 5-6, csukasi2023skeletaldiseasescaused pages 8-9)

Suggested GO biological-process terms: endochondral ossification (GO:0001958); cartilage development (GO:0051216); chondrocyte differentiation (GO:0002062); regulation of chondrocyte differentiation (GO:0032330); bone mineralization (GO:0030282); cAMP-mediated signaling (GO:0019933); adenylate-cyclase-activating GPCR signaling (GO:0007189); skeletal-system development (GO:0001501); blood-vessel development (GO:0001568); Notch signaling (GO:0007219).

Suggested Cell Ontology terms: chondrocyte CL:0000138; hypertrophic chondrocyte (current CL child term should be release-checked); osteoblast CL:0000062; mesenchymal stem cell CL:0000134; vascular endothelial cell CL:0000115.

Subcellular components: plasma membrane (GO:0005886), receptor complex (GO:0043235), cytoplasm (GO:0005737), nucleus (GO:0005634). There is no evidence that BOCD is primarily mitochondrial, lysosomal, ER-storage, inflammatory, autoimmune, or metabolic.

7. Anatomical structures affected

Primary: appendicular and axial skeleton, fetal growth plates, epiphyseal cartilage, ribs, craniofacial skeleton, laryngeal cartilage, carpal/tarsal elements, patellae, and developing teeth. Suggested UBERON mappings include growth plate cartilage UBERON:0004766, cartilage tissue UBERON:0002418, bone tissue UBERON:0002481, rib UBERON:0002228, lung UBERON:0002048, mandible UBERON:0001684, and aorta UBERON:0000947.

Secondary: lungs are hypoplastic because of thoracic restriction; the aorta may show preductal coarctation; mammary glands/nipples may be absent; congenital cataracts are occasional. (portalescastillo2025humandiseasescaused pages 2-4, hoogendam2007novelmutationsin pages 2-3)

The skeletal involvement is generalized and usually symmetric; no consistent lateralization is described.

8. Temporal development

  • Onset: embryonic/fetal, during endochondral skeletal development.
  • Prenatal recognition: possible in the first trimester in recurrent families and later through ultrasound evidence of short dense bones, small thorax, and polyhydramnios; historical literature contains a first-trimester diagnosis report. (portalescastillo2025humandiseasescaused pages 8-8)
  • Course: continuously developmental rather than episodic or relapsing. Ossification becomes excessively advanced with gestation.
  • End stage: miscarriage, termination after prenatal diagnosis, stillbirth, or death shortly after delivery from respiratory failure/pulmonary hypoplasia.
  • Remission/recovery: none known.
  • Critical period: early fetal growth-plate development. Intervention after severe thoracic and pulmonary maldevelopment would be unlikely to reverse anatomy; no prenatal molecular therapy has been tested.

9. Inheritance and population

BOCD is autosomal recessive. If both parents carry pathogenic alleles in the same gene, each pregnancy has the conventional Mendelian probabilities of 25% affected, 50% carrier, and 25% unaffected/noncarrier, assuming confirmed parental carrier status and no unusual allele behavior.

Penetrance of severe biallelic null genotypes appears high, but a formal penetrance estimate is impossible. Expressivity varies with residual receptor function: complete inactivation is associated with type I, whereas hypomorphic alleles can produce type II. Much milder biallelic PTH1R phenotypes—Eiken syndrome, PTH resistance, and tooth-eruption failure—show that genotype–phenotype prediction must incorporate functional severity rather than merely “biallelic versus monoallelic.” (portalescastillo2025humandiseasescaused pages 2-4, hoogendam2007novelmutationsin pages 7-8, hoogendam2007novelmutationsin pages 1-2)

No anticipation, established germline-mosaicism series, founder effect, carrier frequency, ethnic enrichment, geographic endemicity, incidence, or prevalence per 100,000 has been established. Cases include European/Caucasian, Asian, and Turkish families and both sexes. Published case numbers remain only in the low tens; this is a literature impression, not a registry-derived statistic. Consanguinity is recurrent but not obligatory. (hoogendam2007novelmutationsin pages 1-2)

10. Diagnostics

Clinical and prenatal approach

  1. Detailed fetal ultrasound: assess long-bone length and density, thoracic size, ribs, craniofacial proportions, lungs, polyhydramnios, edema/hydrops, and associated cardiac anatomy.
  2. Fetal radiography or low-dose CT where clinically justified: demonstrates generalized osteosclerosis and markedly advanced ossification, including unusually early carpal, tarsal, patellar, and laryngeal-cartilage mineralization.
  3. Fetal echocardiography: evaluate the aortic arch because coarctation is reported.
  4. Molecular confirmation: sequence PTH1R and perform deletion/duplication analysis if sequencing is negative. Parental testing establishes phase and recurrence risk.
  5. Postmortem examination: skeletal survey, lung and cardiovascular examination, and growth-plate histology are valuable for definitive diagnosis and counseling.

The primary series explicitly combined “clinical, radiographical, histological, and biochemical” criteria with PTH1R analysis. (hoogendam2007novelmutationsin pages 1-2, hoogendam2007novelmutationsin pages 2-3)

Genetic-test selection

  • Known familial variant: targeted testing by chorionic-villus sampling or amniocentesis is preferred.
  • Strong BOCD phenotype: single-gene PTH1R testing or a lethal skeletal-dysplasia panel with copy-number analysis.
  • Uncertain skeletal dysplasia: trio WES/WGS can identify PTH1R and phenocopies. WGS is useful for deep-intronic/structural lesions; a 2007 type-I case had no coding or splice-boundary variant detected, illustrating that standard exon sequencing can miss a causal lesion. (hoogendam2007novelmutationsin pages 1-2, hoogendam2007novelmutationsin pages 3-5)
  • CMA/karyotype: useful for a broader fetal-anomaly differential, but not the primary assay for this single-gene disorder.
  • FISH, mitochondrial testing, repeat-expansion testing, RNA-omics, proteomics, metabolomics, epigenomics, and liquid biopsy: not routine BOCD tests.
  • RNA studies: useful when a splice variant is suspected; RT-PCR demonstrated preferential aberrant splicing and residual normal transcript for intron M4+27C>T. (hoogendam2007novelmutationsin pages 7-8, hoogendam2007novelmutationsin pages 3-5)

Differential diagnosis

Important alternatives include other lethal skeletal dysplasias—thanatophoric dysplasia, achondrogenesis, osteogenesis imperfecta type II, hypophosphatasia, short-rib thoracic dysplasias, campomelic dysplasia, and perinatal hypophosphatasia. Advanced generalized ossification/osteosclerosis, premature patellar/carpal/tarsal/laryngeal ossification, reduced growth-plate proliferation, and biallelic PTH1R loss distinguish BOCD. PTH1R-related differentials include Eiken syndrome, which has delayed rather than accelerated ossification; activating-PTH1R Jansen metaphyseal chondrodysplasia; and heterozygous PTH1R-associated primary failure of tooth eruption. (hoogendam2007novelmutationsin pages 1-2, risom2013identificationofsix pages 7-7, portalescastillo2025humandiseasescaused pages 2-4)

There are no consensus society diagnostic criteria, newborn screening, biochemical screening biomarker, or validated prenatal risk calculator.

11. Outcome and prognosis

Prognosis is uniformly grave for classic BOCD. A 32-week infant did not breathe and died within minutes; autopsy showed pulmonary hypoplasia and preductal aortic coarctation. The literature’s first described infant was delivered at 22 weeks and died shortly afterward. (portalescastillo2025humandiseasescaused pages 2-4, hoogendam2007novelmutationsin pages 2-3)

No five- or ten-year survival statistics exist because classic disease is prenatal/perinatal lethal. The proximate mechanism is restrictive thoracic maldevelopment and lung hypoplasia; cardiovascular abnormalities may add risk. Type II is radiographically less severe but remains lethal. No validated prognostic biomarker exists beyond genotype/function and the severity of thoracic/pulmonary involvement. (portalescastillo2025humandiseasescaused pages 1-2, hoogendam2007novelmutationsin pages 1-2)

12. Treatment

No approved pharmacotherapy, gene therapy, cell therapy, RNA therapy, surgery, or disease-modifying prenatal intervention exists. A search of ClinicalTrials.gov retrieved no relevant BOCD-specific interventional trial or NCT identifier.

Management is therefore:

  • multidisciplinary prenatal diagnosis and counseling;
  • fetal echocardiographic and obstetric assessment;
  • discussion of pregnancy options according to local law and family values;
  • delivery planning that avoids futile traumatic intervention where lethality is certain;
  • neonatal comfort care/palliative respiratory support when appropriate;
  • autopsy/tissue preservation and molecular confirmation;
  • psychological and bereavement support.

Suggested NCIT intervention concepts include Genetic Counseling, Prenatal Genetic Testing, Palliative Care, Supportive Care, and Whole Exome Sequencing; exact NCIT codes should be mapped in the current release.

PTH or PTHrP replacement is not an established therapy: severe receptor-null disease cannot be corrected simply by supplying more ligand. Experimental PTH1R inverse agonists developed for activating Jansen disease address the opposite signaling defect and are not applicable to BOCD. The 2023 DEPTOR–TAZ findings remain preclinical and do not constitute a treatment. (csukasi2023skeletaldiseasescaused pages 6-8, csukasi2023skeletaldiseasescaused pages 8-9)

13. Prevention

  • Primary prevention: no lifestyle or environmental prevention is possible.
  • Reproductive prevention/choice: carrier testing for relatives after identification of the familial alleles; preimplantation genetic testing for monogenic disease; targeted prenatal diagnosis by CVS or amniocentesis; early expert ultrasound.
  • Secondary prevention: early fetal diagnosis prevents diagnostic uncertainty and permits informed pregnancy and delivery planning, but does not prevent disease progression.
  • Tertiary prevention: comfort-focused perinatal care can reduce suffering; there is no way to prevent the lethal skeletal/pulmonary complication after it is established.
  • Immunization, public-health sanitation, exposure reduction, and medication prophylaxis: not applicable.

14. Other species and natural disease

No well-established naturally occurring veterinary counterpart or breed predisposition was identified. Therefore, OMIA/VBO breed mapping and veterinary prevalence cannot presently be supplied. PTH1R signaling is evolutionarily conserved across vertebrates, but experimental phenocopies should not be labeled naturally occurring disease. There is no zoonotic potential or cross-species transmission.

15. Model organisms and experimental systems

Mouse

Pth1r-null and Pthlh/PTHrP-null mice die neonatally and show shortened bones, abbreviated proliferative zones, disrupted growth-plate organization, premature hypertrophy and accelerated ossification, closely phenocopying human BOCD. Transgenic PTHrP expression in proliferating chondrocytes partially rescues Pthlh-null lethality, establishing tissue-specific pathway causality. Limitations include species-specific anatomy and the absence of human allelic heterogeneity. (martin2016parathyroidhormonerelatedprotein pages 19-20, portalescastillo2025humandiseasescaused pages 1-2, portalescastillo2025humandiseasescaused pages 2-4)

Zebrafish

Morpholino knockdown of either pthr1 or pthrp caused a localized mid-aortic occlusion from endothelial loss, preceded by defective hypochordal Notch signaling; inducible Notch upregulation rescued the lesion. The abstract states: “Loss of function of either PTHR1 or PTHrP leads to a localized aortic defect that is Notch dependent.” This supports, but does not prove, a direct mechanism for human BOCD-associated coarctation. Morpholino partial knockdown and differences between fish aortic occlusion and human coarctation are major limitations. Gray et al., June 2013, DOI: https://doi.org/10.1161/ATVBAHA.112.300590. (gray2013lossoffunction pages 5-6, gray2013lossoffunction pages 1-2)

Human tissue and cellular systems

Patient fetal growth plates provide the most disease-proximal pathology evidence. Patient dermal fibroblasts and transfected COS-7 cells established loss of PTH/PTHrP-induced cAMP signaling and residual activity for hypomorphic variants. These cells are useful for receptor pharmacology but do not fully reproduce growth-plate differentiation. (hoogendam2007novelmutationsin pages 2-3, hoogendam2007novelmutationsin pages 3-5)

The 2023 DEPTOR study used BOCD tissue, immortalized mesenchymal stem cells, HEK293T interaction assays, and Jansen fibroblasts. It linked DEPTOR–DVL2–TAZ to skeletal lineage choice, but lacked BOCD patient-derived progenitor cells and direct rescue of the lethal phenotype. Csukasi et al., January 2023, DOI: https://doi.org/10.3389/fcell.2022.963389. (csukasi2023skeletaldiseasescaused pages 6-8, csukasi2023skeletaldiseasescaused pages 5-6, csukasi2023skeletaldiseasescaused pages 8-9)

No validated BOCD iPSC, organoid, single-cell atlas, spatial-transcriptomic dataset, CRISPR screen, or integrated disease-specific proteomic/metabolomic/lipidomic signature was identified.

Recent developments, 2023–2024, and expert assessment

The most disease-relevant 2023 advance was the identification of abnormal BOCD skeletal-progenitor patterning and low DEPTOR in ectopic chondrocytes, with a proposed DEPTOR–DVL2–TAZ mechanism. It expands BOCD biology beyond a simple “premature hypertrophy” model, but remains partly extrapolative because BOCD living cells were unavailable. (csukasi2023skeletaldiseasescaused pages 6-8, csukasi2023skeletaldiseasescaused pages 2-5, csukasi2023skeletaldiseasescaused pages 1-2)

A 2024 PTH1R family study concerned a heterozygous allele and incomplete penetrance in a broader PTH1R phenotype, not classic recessive lethal BOCD. Its relevance is chiefly interpretive: PTH1R variant effect, zygosity, receptor domain, and residual signaling—not gene name alone—determine phenotype. No 2023–2024 BOCD therapeutic trial, epidemiologic cohort, single-cell study, or survival improvement was identified.

The current expert view is consequently stable: classic BOCD is a receptor-loss developmental disorder in which complete PTH1R inactivation produces type-I disease, while residual activity can soften skeletal morphology to type II without reliably restoring viability. Recent mechanistic work refines downstream lineage biology, but diagnosis and family planning—not treatment—remain the principal real-world applications. (csukasi2023skeletaldiseasescaused pages 8-9, portalescastillo2025humandiseasescaused pages 2-4, hoogendam2007novelmutationsin pages 1-2)

Evidence limitations

The evidence base comprises very few fetuses, heterogeneous historical reports, postmortem ascertainment, and model systems. Apparent frequencies—including the approximately 50% estimate for aortic coarctation—must not be treated as population estimates. There are no registries large enough to establish incidence, penetrance, sex ratio, carrier frequency, survival curves, quality-of-life scores, or treatment-response rates. Primary-study PMIDs were not consistently present in the retrieved full texts; DOI URLs have therefore been supplied rather than inventing unverified PMID mappings.

References

  1. (portalescastillo2025humandiseasescaused pages 1-2): Ignacio Portales-Castillo, Jakob Höppner, Harald Jüppner, and Thomas J. Gardella. Human diseases caused by homozygous pth1r mutations. Frontiers in Endocrinology, Aug 2025. URL: https://doi.org/10.3389/fendo.2025.1641292, doi:10.3389/fendo.2025.1641292. This article has 4 citations.

  2. (hoogendam2007novelmutationsin pages 1-2): J. Hoogendam, H. Farih‐Sips, L. C. Wÿnaendts, Clemens W.G.M. Löwik, J. Wit, and Marcel Karperien. Novel mutations in the parathyroid hormone (pth)/pth-related peptide receptor type 1 causing blomstrand osteochondrodysplasia types i and ii. The Journal of clinical endocrinology and metabolism, 92 3:1088-95, Mar 2007. URL: https://doi.org/10.1210/jc.2006-0300, doi:10.1210/jc.2006-0300. This article has 62 citations.

  3. (portalescastillo2025humandiseasescaused pages 8-8): Ignacio Portales-Castillo, Jakob Höppner, Harald Jüppner, and Thomas J. Gardella. Human diseases caused by homozygous pth1r mutations. Frontiers in Endocrinology, Aug 2025. URL: https://doi.org/10.3389/fendo.2025.1641292, doi:10.3389/fendo.2025.1641292. This article has 4 citations.

  4. (portalescastillo2025humandiseasescaused pages 2-4): Ignacio Portales-Castillo, Jakob Höppner, Harald Jüppner, and Thomas J. Gardella. Human diseases caused by homozygous pth1r mutations. Frontiers in Endocrinology, Aug 2025. URL: https://doi.org/10.3389/fendo.2025.1641292, doi:10.3389/fendo.2025.1641292. This article has 4 citations.

  5. (martin2016parathyroidhormonerelatedprotein pages 19-20): T. John Martin. Parathyroid hormone-related protein, its regulation of cartilage and bone development, and role in treating bone diseases. Physiological reviews, 96 3:831-71, Jul 2016. URL: https://doi.org/10.1152/physrev.00031.2015, doi:10.1152/physrev.00031.2015. This article has 203 citations and is from a highest quality peer-reviewed journal.

  6. (hoogendam2007novelmutationsin pages 2-3): J. Hoogendam, H. Farih‐Sips, L. C. Wÿnaendts, Clemens W.G.M. Löwik, J. Wit, and Marcel Karperien. Novel mutations in the parathyroid hormone (pth)/pth-related peptide receptor type 1 causing blomstrand osteochondrodysplasia types i and ii. The Journal of clinical endocrinology and metabolism, 92 3:1088-95, Mar 2007. URL: https://doi.org/10.1210/jc.2006-0300, doi:10.1210/jc.2006-0300. This article has 62 citations.

  7. (csukasi2023skeletaldiseasescaused pages 2-5): Fabiana Csukasi, Michaela Bosakova, Tomas Barta, Jorge H. Martin, Jesus Arcedo, Maya Barad, Gustavo A. Rico-Llanos, Jennifer Zieba, Jose Becerra, Pavel Krejci, Ivan Duran, and Deborah Krakow. Skeletal diseases caused by mutations in pth1r show aberrant differentiation of skeletal progenitors due to dysregulation of deptor. Frontiers in Cell and Developmental Biology, Jan 2023. URL: https://doi.org/10.3389/fcell.2022.963389, doi:10.3389/fcell.2022.963389. This article has 5 citations.

  8. (hoogendam2007novelmutationsin pages 3-5): J. Hoogendam, H. Farih‐Sips, L. C. Wÿnaendts, Clemens W.G.M. Löwik, J. Wit, and Marcel Karperien. Novel mutations in the parathyroid hormone (pth)/pth-related peptide receptor type 1 causing blomstrand osteochondrodysplasia types i and ii. The Journal of clinical endocrinology and metabolism, 92 3:1088-95, Mar 2007. URL: https://doi.org/10.1210/jc.2006-0300, doi:10.1210/jc.2006-0300. This article has 62 citations.

  9. (hoogendam2007novelmutationsin pages 7-8): J. Hoogendam, H. Farih‐Sips, L. C. Wÿnaendts, Clemens W.G.M. Löwik, J. Wit, and Marcel Karperien. Novel mutations in the parathyroid hormone (pth)/pth-related peptide receptor type 1 causing blomstrand osteochondrodysplasia types i and ii. The Journal of clinical endocrinology and metabolism, 92 3:1088-95, Mar 2007. URL: https://doi.org/10.1210/jc.2006-0300, doi:10.1210/jc.2006-0300. This article has 62 citations.

  10. (risom2013identificationofsix pages 7-7): Lotte Risom, Line Christoffersen, Jette Daugaard-Jensen, Hanne Dahlgaard Hove, Henriette Skovgaard Andersen, Brage Storstein Andresen, Sven Kreiborg, and Morten Duno. Identification of six novel pth1r mutations in families with a history of primary failure of tooth eruption. PLoS ONE, 8:e74601, Sep 2013. URL: https://doi.org/10.1371/journal.pone.0074601, doi:10.1371/journal.pone.0074601. This article has 76 citations and is from a peer-reviewed journal.

  11. (guasto2021signalingpathwaysin pages 7-8): Alessandra Guasto and Valérie Cormier-Daire. Signaling pathways in bone development and their related skeletal dysplasia. International Journal of Molecular Sciences, 22:4321, Apr 2021. URL: https://doi.org/10.3390/ijms22094321, doi:10.3390/ijms22094321. This article has 106 citations.

  12. (lai2008generegulationin pages 19-24): LP Lai. Gene regulation in growth plate chondrocytes by the parathyroid hormone 1 receptor and the beta2-adrenergic receptor. Unknown journal, 2008.

  13. (nishimori2019pthrptargetshdac4 pages 17-17): Shigeki Nishimori, Forest Lai, Mieno Shiraishi, Tatsuya Kobayashi, Elena Kozhemyakina, Tso-Pang Yao, Andrew B. Lassar, and Henry M. Kronenberg. Pthrp targets hdac4 and hdac5 to repress chondrocyte hypertrophy. JCI insight, Mar 2019. URL: https://doi.org/10.1172/jci.insight.97903, doi:10.1172/jci.insight.97903. This article has 64 citations and is from a domain leading peer-reviewed journal.

  14. (gray2013lossoffunction pages 5-6): Caroline Gray, David Bratt, Julie Lees, Marc daCosta, Karen Plant, Oliver J. Watson, Sara Solaymani-Kohal, Simon Tazzyman, Jovana Serbanovic-Canic, David C. Crossman, Bernard D. Keavney, Andrea Haase, Kathryn McMahon, Martin Gering, Henry Roehl, Paul C. Evans, and Timothy J.A. Chico. Loss of function of parathyroid hormone receptor 1 induces notch-dependent aortic defects during zebrafish vascular development. Arteriosclerosis, Thrombosis, and Vascular Biology, 33:1257–1263, Jun 2013. URL: https://doi.org/10.1161/atvbaha.112.300590, doi:10.1161/atvbaha.112.300590. This article has 16 citations and is from a domain leading peer-reviewed journal.

  15. (gray2013lossoffunction pages 1-2): Caroline Gray, David Bratt, Julie Lees, Marc daCosta, Karen Plant, Oliver J. Watson, Sara Solaymani-Kohal, Simon Tazzyman, Jovana Serbanovic-Canic, David C. Crossman, Bernard D. Keavney, Andrea Haase, Kathryn McMahon, Martin Gering, Henry Roehl, Paul C. Evans, and Timothy J.A. Chico. Loss of function of parathyroid hormone receptor 1 induces notch-dependent aortic defects during zebrafish vascular development. Arteriosclerosis, Thrombosis, and Vascular Biology, 33:1257–1263, Jun 2013. URL: https://doi.org/10.1161/atvbaha.112.300590, doi:10.1161/atvbaha.112.300590. This article has 16 citations and is from a domain leading peer-reviewed journal.

  16. (csukasi2023skeletaldiseasescaused pages 6-8): Fabiana Csukasi, Michaela Bosakova, Tomas Barta, Jorge H. Martin, Jesus Arcedo, Maya Barad, Gustavo A. Rico-Llanos, Jennifer Zieba, Jose Becerra, Pavel Krejci, Ivan Duran, and Deborah Krakow. Skeletal diseases caused by mutations in pth1r show aberrant differentiation of skeletal progenitors due to dysregulation of deptor. Frontiers in Cell and Developmental Biology, Jan 2023. URL: https://doi.org/10.3389/fcell.2022.963389, doi:10.3389/fcell.2022.963389. This article has 5 citations.

  17. (csukasi2023skeletaldiseasescaused pages 8-9): Fabiana Csukasi, Michaela Bosakova, Tomas Barta, Jorge H. Martin, Jesus Arcedo, Maya Barad, Gustavo A. Rico-Llanos, Jennifer Zieba, Jose Becerra, Pavel Krejci, Ivan Duran, and Deborah Krakow. Skeletal diseases caused by mutations in pth1r show aberrant differentiation of skeletal progenitors due to dysregulation of deptor. Frontiers in Cell and Developmental Biology, Jan 2023. URL: https://doi.org/10.3389/fcell.2022.963389, doi:10.3389/fcell.2022.963389. This article has 5 citations.

  18. (guasto2021signalingpathwaysin pages 18-19): Alessandra Guasto and Valérie Cormier-Daire. Signaling pathways in bone development and their related skeletal dysplasia. International Journal of Molecular Sciences, 22:4321, Apr 2021. URL: https://doi.org/10.3390/ijms22094321, doi:10.3390/ijms22094321. This article has 106 citations.

  19. (csukasi2023skeletaldiseasescaused pages 5-6): Fabiana Csukasi, Michaela Bosakova, Tomas Barta, Jorge H. Martin, Jesus Arcedo, Maya Barad, Gustavo A. Rico-Llanos, Jennifer Zieba, Jose Becerra, Pavel Krejci, Ivan Duran, and Deborah Krakow. Skeletal diseases caused by mutations in pth1r show aberrant differentiation of skeletal progenitors due to dysregulation of deptor. Frontiers in Cell and Developmental Biology, Jan 2023. URL: https://doi.org/10.3389/fcell.2022.963389, doi:10.3389/fcell.2022.963389. This article has 5 citations.

  20. (csukasi2023skeletaldiseasescaused pages 1-2): Fabiana Csukasi, Michaela Bosakova, Tomas Barta, Jorge H. Martin, Jesus Arcedo, Maya Barad, Gustavo A. Rico-Llanos, Jennifer Zieba, Jose Becerra, Pavel Krejci, Ivan Duran, and Deborah Krakow. Skeletal diseases caused by mutations in pth1r show aberrant differentiation of skeletal progenitors due to dysregulation of deptor. Frontiers in Cell and Developmental Biology, Jan 2023. URL: https://doi.org/10.3389/fcell.2022.963389, doi:10.3389/fcell.2022.963389. This article has 5 citations.

Artifacts

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome Count
References checked 9
Resolved 9
Unresolved (possible confabulation) 0
Unverifiable 0
References weighed for topical relevance 9
On topic 2
Off topic 0

All extracted references resolved successfully.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome Count
Terms checked 51
Resolved 48
Unresolved (possible confabulation) 1
Obsolete 1
Unverifiable 1

Unresolved terms

These identifiers do not exist in an ontology that resolved other terms from the same prefix, so they were most likely invented:

  • HP:0002796 (1 mention) - HP does not contain this term

Obsolete terms

These terms are real but deprecated. Citing one is not a fabrication; it does mean the report is naming something the ontology has retired:

  • GO:0019933 (obsolete cAMP-mediated signaling) (1 mention)

Prefixes with no resolver

Terms carrying these prefixes were not checked either way, because no configured ontology covers them. An unrecognised prefix may name an ontology this run could not reach as easily as one that does not exist, so nothing here is evidence of fabrication: OMIM.